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Abstract

FRAILTY AND DEPRESSION: A LATENT TRAIT ANALYSIS
By Matthew Christopher Lohman
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2014
Director: Briana Mezuk. Ph.D.
Assistant Professor
Division of Epidemiology, Department of Family Medicine and Population Health

Background: Frailty, a state indicating vulnerability to poor health outcomes, is a common
condition in later life. However, research and intervention progress is hindered by the current
lack of a consensus frailty definition and poor understanding of relationships between frailty and
depression.
Objectives: The goal of this research is to understand the interrelationships between frailty and
depression among older adults. Specifically, this project aims 1) to examine the construct overlap
between depression and three definitions of frailty (biological syndrome, medical burdens, and
functional domains), 2) to determine the degree to which this overlap varies by age, gender,
race/ethnicity and other individual characteristics, 3) to evaluate how the association between
frailty and depression influences prediction of adverse health outcomes.
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Methods: This project uses data from the 2004-2012 Health and Retirement Study (HRS), an
ongoing, nationally-representative cohort study of adults over the age of 55. Frailty was indexed
by three alternative conceptual models: 1) biological syndrome, 2) cumulative medical burdens,
and 3) functional domains. Depressive symptoms were indexed by the 8-item Center for
Epidemiologic Studies Depression (CESD) scale. Latent class analysis and confirmatory factor
analysis were used to assess the construct overlap between depressive symptoms and frailty.
Latent growth curve modeling were used to evaluate associations between frailty and depression,
and to estimate their joint influence on two adverse health outcomes: nursing home admission
and falls.
Results: The measurement overlap of frailty and depression was high using a categorical latent
variable approach. Approximately 73% of individuals with severe depressive symptoms, and
85% of individuals with primarily somatic depressive symptoms, were categorized as
concurrently frail. When modeled as continuous latent factors, each of the three frailty latent
factors was significantly correlated with depression: biological syndrome (ρ = .67, p <.01);
functional domains (ρ = .70, p <.01); and medical burdens (ρ = .62, p <.01). Higher latent frailty
trajectories were associated with higher likelihood of experiencing nursing home admission and
serious falls. This association with adverse health outcomes was attenuated after adjustment for
depression as a time-varying covariate.
Conclusions: Findings suggest that frailty and frailty trajectories are potentially important
indicators of vulnerability to adverse health outcomes. Future investigations of frailty syndrome,

vii

however it is operationalized, should account for its substantial association with depression in
order to develop more accurate measurement and effective treatment.

viii

Chapter 1: Background

The proportion of older adults in the US population is growing, and by 2030,
approximately one in five Americans will be age 65 or older. The prevention of disability and
unintentional injuries among older adults is a key objective for promoting health and well-being
as part of the National Prevention Plan and Healthy People 2020 (1, 2). For example, falls affect
one in three adults age 65 and older each year and are the leading cause of death due to
unintentional injury among this age group (1, 3). There is increasing concern that acquired
functional limitations and disabilities will increase the demand for long-term healthcare services
in later life (1). As a result, increased emphasis is being placed on reducing the need for future
formal and informal healthcare by promoting healthy lifestyles, strengthening physiologic
reserve, and addressing vulnerability to adverse health outcomes before they occur (1, 2).
Frailty as a geriatric syndrome
Preventive approaches which target risk factors and or promote resiliency to physical
challenges are thus primary means to prevent disability for older adults. Frailty is a geriatric
syndrome that indicates multi-system susceptibilities to preventable injury and health decline and
may be useful for targeting prevention efforts and allocating health resources. The identification
and measurement of geriatric syndromes that indicate at-risk individuals are critical to prevention
efforts because they are believed to be modifiable targets for timely intervention (4). Several
approaches to reducing the prevalence and severity of frailty among older adults have been
investigated with varying degrees of success (5). In clinical settings, care management of frail
older adults is associated with lower mortality relative to usual care (6). Exercise training and
nutrition interventions aimed at improving muscle strength and balance have had mixed success
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at improving mobility and functional abilities among frail older adults in both institutional and
home-based settings (7, 8). There is even suggestion that some pharmacologic agents may be
viable treatments for addressing frailty symptoms. For instance angiotensin-converting enzyme
inhibitors may be effective at slowing age-related muscle loss; however there is little clinical
evidence to support the effectiveness of such treatments among frail individuals (9, 10). In sum,
frailty may be an important tool for directing public health and clinical approaches to care among
older adults and is a practical concept with broad applicability.
Apart from being a treatable condition itself, frailty may be informative for determining
other healthcare interventions. For instance, frailty has been used as a measure of suitability for
surgery, medication, and transplantation (11-14). Frailty in this context may help vulnerable
(frail) individuals avoid potentially harmful interventions, and at the same time, help ensure that
healthy (non-frail) older adults receive beneficial care from which they might otherwise be
excluded due to age. Frailty then can be seen as a more refined measure of physiological age that
is not adequately captured by chronological age alone. However, adoption of frailty, whether as a
screening tool or as a sign of poor physiologic reserve, is contingent on the validity and
reliability of its measurement.
The potential benefits of frailty as a marker of vulnerability are predicated on the ability
to correctly and reliably identify older adults as frail. However, in practice, numerous distinct
definitions and operationalizations of frailty are invoked depending on the context. Conceptual
differences determine which domains, symptoms and dimensions are incorporated into the
various proposed definitions (4, 15, 16). Frailty has been conceptualized as both distinct from
and synonymous with comorbidity, disability, and functional limitations (17, 18). Indeed, the
various existing definitions of frailty include symptoms that tap into psychological (19, 20),
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cognitive (21-23), sensory (24), and even social domains (25-27). Still others suggest that a
universally applicable definition of frailty is not possible and that frailty is simply a socially
constructed entity (13, 28). It is clear from these contradictions that frailty is a concept still in
development.
Frailty and depression in later life
It is unclear how the aforementioned concerns regarding the validity and reliability of
current operationalizations of frailty impact the relationship between this syndrome and other
health conditions in later life, particularly depression. Depression is an important example of a
condition which shares many features and correlates with frailty. First, depression, like frailty, is
a common disorder in late life. While the prevalence of major depressive episodes may be
relatively low among older adults, the prevalence of clinically significant depressive symptoms
is high and is highest among the oldest old (aged 85 years or older) (29, 30). This is often
attributed to a greater prevalence of physical disability and cognitive impairment in later life
(31). Second, frailty and depression may share common symptoms and predictors, and may
predict similar vulnerability to poor health outcomes and mortality. Third, it has been argued that
because of a high degree of comorbidity and conceptual similarity, that frailty and depression
may be considered causes of each other, forms of each other, or even interchangeable clinical
entities (32-39). Research has demonstrated that existing models of frailty and depression
identify concordant populations more than expected by chance or by definitional overlap alone
(33, 40). Older adults are more likely to report ‘somatic’ symptoms of depression such as sleep
disturbance and fatigue (41), suggesting that frailty and depression may be forms of a similar
vulnerability which increases with age. Antidepressant use is also associated with higher risk of
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frailty incidence, suggesting that adverse effects of pharmacotherapy may contribute to risk of
frailty, or that older adults with more severe depression are at higher risk of frailty (42).
The complex and uncertain nature of the association between frailty and depression
indicates the need for focused investigation of these constructs and how they jointly influence
aging and health. There are many practical reasons to distinguish between and measure these two
concepts. First, frailty may influence effectiveness of and adherence to treatments for depression
or vice versa (43, 44). Second, comorbidity of frailty and depression may signal more complex
health concerns that may not be adequately addressed by treatments focused on only one
condition (15). Prior research has suggested that individuals with comorbid frailty and
depression would benefit from more holistic care strategies that address both psychosocial and
physiological vulnerabilities (45). Third, comorbid frailty and depression may be premorbid
indicators of a more fundamental process of decline such as cardiovascular disorder or dementia,
and so the co-occurrence of the two disorders may be of clinical value. Fourth, from a research
standpoint, the investigation of these constructs may serve to bridge the gap between two parallel
lines of research in frailty and late-life depression. Consideration of both constructs thus provides
generative information for future research.
This project aims to investigate the associations between frailty and depression and to
describe their combined role in predicting and influencing health in later life using various latent
variable techniques. Latent variable techniques are well-suited to investigating these questions
because they help to account for measurement error inherent in studying syndromes which
cannot be directly observed, like frailty and depression. Explaining the relationships and
boundaries between these constructs is an important goal, because without these advances, a
consensus frailty definition is less likely to emerge. By providing clarity about frailty as a
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diagnostic entity we will aid future efforts to identify and intervene on frailty syndrome.
Although frailty is a promising diagnostic and organizational construct for geriatrics, the realworld benefits of being able to predict and prevent injury and disability among older adults will
not be realized until conceptual and definitional issues are resolved.

5

Chapter 2: Gender Differences in the Construct Overlap of Frailty and
Depression: Evidence from the Health and Retirement Study
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ABSTRACT
Objectives: To determine the measurement overlap of common definitions of frailty and depression
and to investigate whether gender differences in symptom endorsement influence the degree of
construct overlap.
Design: Cross-sectional latent class analysis.
Setting: Data come from the 2008 wave of the Health and Retirement Study, a nationallyrepresentative longitudinal survey of health characteristics among older adults.
Participants: Community-dwelling adults aged 65 and older completing a general health
questionnaire and consenting to physical measurements (N=3,665).
Measurements: Frailty was measured using criteria developed in the Cardiovascular Health Study
and depression was measured using items from the 8-item Centers for Epidemiologic Studies
Depression (CESD) scale.
Results: Frailty and depression were best modelled as two distinct but highly correlated constructs
with 3-classes and 4-classes of symptom response respectively. Measurement overlap was high
among both men and women. Approximately 73% of individuals with severe depressive symptoms,
and 85% of individuals with primarily somatic depressive symptoms, were categorized as
concurrently frail. The degree of construct overlap between depression and frailty did not
significantly vary by gender, but women were significantly more likely to endorse all frailty and
depressive symptoms.
Conclusion: Findings suggest that common operational definitions of depression and frailty
identify substantially overlapping populations of older men and women. More frequent
endorsement of depressive symptoms, but not differential endorsement of somatic symptoms in
particular, may contribute to the higher prevalence of frailty among women. Future research should
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further describe the relationship between frailty and depression and focus on developing better
means to discriminate between these constructs.
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INTRODUCTION
Frailty, a syndrome characterized by greater vulnerability to morbidity and mortality in
later life, affects approximately one in 10 older adults (46-48). Frailty is increasingly recognized
as an important predictor of disability and other poor health outcomes, including falls,
hospitalization and mortality (4, 15, 18). One principal justification for distinguishing frailty as
an independent health state is the potential to identify older adults prior to adverse events and to
intervene to delay or prevent disability (4, 15, 18). However, conceptual disagreements about the
components and symptoms that define frailty limit the ability of this syndrome to accurately
identify affected individuals and to develop meaningful approaches to treatment (26, 48).
The construct proposed by Fried and colleagues defines frailty as a syndrome of five
biologic deficits distinct from comorbidity, disability, or a particular disease process (18, 26, 49).
Previous research supports the existence of a phenotype characterized by co-occurrence of these
deficits (50); however, the existence of this biologically-rooted phenotype does not preclude the
predictive utility of additional non-biological criteria. Indeed, alternative definitions of frailty
include symptoms that tap into psychological (19, 20), cognitive (21, 22), and sensory (24)
domains (25, 26). These symptoms capture elements of biological age, psychosocial
vulnerability, and medical morbidity, and, as might be expected with such a range of indicators,
the different conceptual interpretations of frailty identify markedly different vulnerable
individuals (48, 51); this in turn suggests that there may be distinct methods of effective
intervention for these groups (48, 51).
The frailty concept is additionally complicated by the potential inability of current
operational schema to discriminate frailty from other geriatric syndromes such as depression
(40). Like frailty, depression is a common condition among older adults and shares symptoms,
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putative causes and possible outcomes with frailty (30, 32, 36). Predictably, the two conditions
are highly comorbid among older adult populations, but the reasons for their co-occurrence are
unclear (23, 33). Older adults with depression are more likely than younger adults to endorse
somatic depressive symptoms such as sleep disturbances and fatigue (41), suggesting that frailty
and depression may be correlated due to shared symptom profiles (akin to the acknowledged
symptom overlap between depression and generalized anxiety disorder) (52). These two
conditions may also represent alternate manifestations of a more general vulnerability to
functional decline which increases with age (53). Despite purportedly measuring conceptually
distinct constructs, emerging research has indicated that common operational definitions of
frailty and depression identify highly concordant populations of afflicted older adults (40), and
thus inferences about these conditions drawn from epidemiologic studies may be biased due to
lack of measurement discrimination.
Research exploring whether factors such as gender influence the degree of measurement
overlap between frailty and depression is limited but warranted. Women are more likely than
men to be identified as frail, regardless of the specific definition of frailty used, and tend to
accumulate more physiological deficits with age (46, 54). Likewise, depression and depressive
symptoms are consistently more common among women (55). Some attribute the gender
difference in depression to the greater prevalence among women of ‘somatic depression,’
characterized by frequent endorsement of somatic, rather than cognitive or mood-related
symptoms (56). The construct overlap of frailty and depression may therefore differ by gender
due to differential endorsement of frailty and depression criteria.
The purpose of this study is two-fold: 1) To confirm the extent of diagnostic overlap
between established indices of frailty and depression among a nationally representative sample
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of older adults; and 2) To explore gender differences in the joint distribution of frailty and
depression symptoms. We hypothesize that common indices of frailty and depression will
identify highly overlapping populations, and predict that the degree of overlap and the types of
symptoms endorsed will differ substantially between men and women.

METHODS
Data and Sample Characteristics
Data for this study come from the 2008 wave of The Health and Retirement Study (HRS),
an ongoing prospective survey of adults aged 51 and over, designed to assess the health,
demographic, and financial characteristics of the aging population (57). As described in detail
elsewhere, the HRS is a nationally-representative multi-stage probability sample (57). HRS
respondents are interviewed every two years, and beginning in 2004, a subset of respondents was
selected at each wave to participate in enhanced face-to-face interviews. The enhanced
interviews include objective measures of physical characteristics such as height, weight, gait
speed, strength, and other indicators of physical functioning (58).
A total of 17,217 respondents were interviewed in the 2008 wave. Respondents were
ineligible to participate in enhanced physical measurement interviews if they were currently
residing in a nursing home (n=460) or interviewed by proxy (n=1,140). Of the 6,931 respondents
who consented to enhanced interviews, 4,552 were aged 65 and over. The current study is
restricted to the 3,665 respondents aged 65 and over who completed physical performance
measures required to determine frailty status. Respondents who completed the physical
performance measures were more likely to be women (t=3.44, p<.001), white (t=8.36, p<.001,
currently married (t=6.50, p<.001) and to have more years of education (t=5.68, p<.001)
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compared to those who were not included, but did not differ significantly with respect to age or
employment status.

Measures
Frailty
Frailty was modeled using criteria derived from the Cardiovascular Health Study (CHS),
including deficits in five areas: low weight, physical inactivity, exhaustion, weakness, and
slowness (49). To the extent possible, operationalization of these criteria approximated or
replicated CHS criteria. Low weight was defined as a self-reported or calculated loss of 10% or
more in BMI since the previous (2006) wave or as a current BMI <18.5 kg/m2. Physical activity
was calculated as the weighted average of self-reported frequency of three intensities of activity
(mild, moderate, and vigorous); physical inactivity was defined as being in the lowest 20% on
the physical activity score stratified by gender. In the CHS, exhaustion was indicated by
endorsement of one of two items from the Center for Epidemiologic Studies – Depression
(CESD) scale. Because the goal of this study is to examine the degree of diagnostic overlap
between depression and frailty, we did not use items from the CESD to indicate frailty. We
instead defined exhaustion as report of persistent or troublesome fatigue or exhaustion within the
past two years. Grip strength of the dominant hand was measured using a dynamometer, and this
value was then averaged across two measurements. Weakness was defined as being in the lowest
quartile of grip strength stratified by gender. Although grip strength was not further stratified by
BMI (as in the CHS) the gender-specific cut-points for weakness (male <29.5 kg; female <17.5
kg) are consistent with CHS stratified measures and conservatively low (49). Gait speed was
assessed using a 2.5-meter course; slowness was defined as a speed <.762 meters/sec for
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individuals >159 cm in height, and as <.653 meters/sec for individuals ≤159 cm tall (49, 50). All
frailty indicators were considered as binary (present/absent) symptoms.
Depression
Depressive symptoms were ascertained using the 8-item version of the Center for
Epidemiological Studies Depression Scale (CESD-8) (59, 60). The CESD-8 assesses the
presence or absence of eight depressive symptoms over the previous week; positive items were
reverse-coded (see footnote of Figure 2.1). Although the CESD-8 is not a substitute for diagnosis
of major depressive disorder (MD), the CESD-8 has moderate agreement with the Composite
International Diagnostic Interview (CIDI), a fully-structured diagnostic interview to assess
presence of MD. In the HRS specifically, the CESD-8 has a sensitivity of .71 and specificity of
.79 compared to the CIDI-assessed MD using a cut-point of CESD-8 ≥ 4 symptoms to indicate
depression (59, 60).
Covariates
Gender, race (categorized as non-Hispanic White, Black, or other), age (years), education
(years), marital status (currently married vs. single/widowed/divorced), current employment
status (full- or part-time vs. no employment), self-rated health (bad/fair vs. good/very
good/excellent), and disability status (presence of any difficulties with activities of daily living
(ADL) or instrumental activities of daily living (IADL)) were assessed by self-report. Cognitive
functioning was assessed using number of correct responses (range: 0 to 10) to selected items
from the Modified Telephone Interview for Cognitive Status (m-TICS) (61, 62).

Analysis
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The bivariate associations between depressive symptoms and demographic
characteristics, health indicators, disability status, and the five frailty indicators were examined
using t-tests for continuous variables and Fisher’s exact tests for categorical variables.
Latent class analysis (LCA) was used to investigate the construct overlap between frailty
and depression. LCA assumes the existence of an underlying categorical latent variable (i.e.
frailty and/or depression) which explains the association between a set of observed variables (i.e.
the respective indicator symptoms of frailty and depression) (63, 64). The purpose of LCA is to
identify discrete subpopulations (classes) of individuals who share similar symptom endorsement
patterns. LCA is appropriate for identifying syndromes, particularly in instances where there is
no consensus as to scope of relevant symptomology. Given a specified number of latent classes
and the values of observed symptoms, LCA uses an iterative maximum-likelihood method to
obtain estimates of two types of parameters: 1) the proportion of the population belonging to a
particular class (unconditional probabilities); and 2) the conditional probabilities of symptom
endorsement given membership in a class. The set of unconditional and conditional probabilities
for a given class describe the features of the class members. To account for the complex
sampling design of the HRS, observations in all LCA models were weighted according to HRS
sample weights indicating probability of selection into the HRS physical measures subsample
(58).
We compared two general types of latent class model in order to determine whether the
association between observed symptoms was best explained by a single latent construct or by
two distinct constructs: 1) a single latent variable model in which all observed variables indicated
a single latent construct (which would be consistent with frailty and depression being alternate
forms of the same underlying syndrome), and 2) a model in which two separate latent variables
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representing frailty and depression were indicated by symptoms from the CHS criteria and
CESD-8 respectively (Figure 2.1). Within the second type of model, a series of additional
models was fit, each specifying different numbers of classes for both depression and frailty. The
explanatory strengths of these models were compared using goodness-of-fit statistics including
Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), and sample-size
adjusted Bayesian Information Criterion (BICN), for which smaller numbers indicate better
relative fit. Goodness-of-fit statistics and interpretability of class features were used to determine
the most likely model.
To examine differences in the joint distribution of frailty and depression symptoms by
gender, we performed a multiple group LCA, comparing a series of models under different
parametric assumptions. The procedure used for multi-group latent class analysis is described in
detail elsewhere (65, 66). To summarize, first, the analytic steps described above were repeated
independently among males and females to ascertain whether the appropriate number of latent
classes was similar across gender. Second, in gender-pooled data, we evaluated the item-level
measurement invariance of the model with respect to gender by comparing the fit of a
heterogeneous (unconstrained) model to a homogenous model in which item-level conditional
probabilities were constrained to be equal across gender. Third, we compared class proportions
from item-level invariant and unconstrained models in order to evaluate whether class
membership varied significantly by gender. The final, best-fitting measurement model was used
to interpret latent class profiles and to compare class sizes across gender.
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RESULTS
The characteristics of the analytic sample stratified by gender and depression status are
shown in Table 2.1. Individuals who reported experiencing at least 4 CESD symptoms were
significantly more likely to be women, to have less years of education and to be currently
unmarried. Elevated depressive symptoms were also associated with presence of functional
disability, lower cognitive performance scores, poorer self-rated health, and higher likelihood of
endorsing all frailty criteria. Women did not differ significantly with men in presence of ADL
disability, self-rated health, or cognitive performance scores; however, women were more likely
to endorse all frailty criteria.

Measurement Invariance by Gender
Table 2.2 displays fit statistics from selected LCA models assuming different numbers of
classes for both frailty and depression. Models which treated frailty and depression as distinct
but correlated latent variables defined by their respective indicator criteria (Figure 2.1)
collectively achieved better fit to the data (indicated by lower fit-statistic values) than the singlelatent-variable model. In overall and gender-specific analyses, the model achieving the best fit to
the data was one in which depression and frailty were represented by separate but correlated
latent variables, with depression described by four latent classes (low, moderate, somatic, and
severe depression) and frailty described by three latent classes (not frail, moderate frailty, and
frailty with exhaustion).
To evaluate item-level measurement invariance by gender, we compared heterogeneous
and constrained models as described above. The homogenous and heterogeneous models
produced comparable fit to the data (BICN = 39486.439 and BICN = 39493.567 respectively),
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indicating that conditional probabilities of symptom endorsement were similar by gender given
membership in a particular class. Unlike conditional probabilities, unconditional class
proportions varied significantly by gender (see Figures 2.2a and 2.2b), indicating that likelihood
of membership in a particular class differed significantly by gender.

Class Characteristics
Figures 2.2a and 2.2b present class proportions and conditional probabilities of frailty and
depression produced by the best-fitting model separately by gender. Conditional probabilities of
the four depression classes were similar by gender (Figure 2.2a). Among both men and women,
three distinct classes of depression characterized by low, moderate and high endorsement of all
criteria were apparent. The fourth class, somatic depression, was characterized by endorsement
of restless sleep, lack of motivation, and feeling activities were an effort. Women were more
likely than men to be in the moderate or severe depression classes. Frailty class conditional
probabilities were also similar by gender (Figure 2.2b). The criterion of exhaustion distinguished
the two classes with the greatest symptom endorsement; the criterion of low BMI did not
discriminate between frailty classes among either men or women, as shown by similar
conditional probabilities for all three classes. Women were more likely than men to be classified
as moderately frail or frail with exhaustion.
Table 2.3 illustrates class overlap of frailty and depression. It is apparent from the table
that membership in particular depression classes is associated with membership in the frailty
classes. For example, among those in the low depression class, only 12.0% were classified in the
moderate frailty class, and 0% were in the frailty with exhaustion class. Among those in the
somatic depression class, 23.1% were classified as moderately frail and 62.1% were classified in
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the frailty with exhaustion class. Similarly those classified in the high depressive symptom
endorsement class (8.6%) were likely to endorse frailty symptoms, with approximately 73%
classified as likely to endorse at least three frailty symptoms.

DISCUSSION
The primary finding of this study is that commonly used criteria for frailty and depression
identify highly-overlapping populations of older adults. Despite the fact that both frailty and
depression are more common among women, there was no evidence that the measurement of
these constructs differs by gender. We found that a substantial proportion of individuals
categorized in the somatic or severe depression classes were also highly likely to meet criteria
for frailty. This indicates that current measurement schema for frailty and depression syndrome
may be poor at discriminating between these syndromes among older populations. The
opportunity for misclassification and misattribution of symptoms given this substantial
measurement overlap implies a need for considering frailty and depression jointly in
epidemiologic study rather than as isolated conditions.
This study replicates recent work from our group that demonstrated substantial construct
overlap between frailty, as defined by CHS criteria, and depression syndrome, as defined by the
Diagnostic Interview Schedule (DIS) (40). In the present study nearly three-quarters of the
individuals in the severe depression class were categorized in either the moderately frail or frail
with exhaustion classes, compared to only 12% of individuals in the low symptom class. The
consistency of overlap between CHS defined frailty and two different operationalizations of
depression syndrome (DIS and CESD-8) suggests that the association between these two
constructs may be explained in part by an underlying conceptual overlap or a common
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underlying factor, rather than features of the measurement tool. For instance, Hajjar and
colleagues have identified a potentially novel geriatric phenotype characterized by concurrent
depressive symptoms, slow gait speed and impaired executive function (67). Similarly, our
findings are consistent with the hypothesis that the co-occurrence of frailty and depression may
be indicative of some common pathology, such as vascular damage to the brain. Vascular
depression, a subtype of depression common among older adults and characterized by slowness,
fatigue and muscular weakness, has been suggested as a prodromal state or early warning sign of
frailty (38). In support of this hypothesis, we found that individuals in the somatic depression
class were also highly likely to be considered frail, with 85% of individuals categorized in the
moderate or frail with exhaustion classes.
In addition to shared pathology, several hypotheses regarding a potential causal
relationship between these conditions have been proposed. For instance, Lakey and colleagues
found that anti-depressant use predicted incident frailty among older women independent of the
association between depressive symptoms and frailty (42). However, as our findings suggest,
even with longitudinal data the attribution of a causal relationship between depression and frailty
is difficult due to measurement overlap. Though the CHS definition of frailty is primarily
biological, excluding cognitive and mood-related symptoms present in other frailty definitions, it
is nevertheless difficult to distinguish between this operationalization of frailty and depression
(40).
Overall, our findings indicate that analytic efforts to treat depression and frailty as
independent constructs, or to exclude individuals with depression from studies of frailty is
misleading and may bias the relationship between frailty and poor health outcomes. Given calls
for a unified approach to conceptualizing and preventing geriatric syndromes (15), an alternative
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approach toward the epidemiologic study of frailty would be to consider frailty and depression
jointly as indicators of a more general vulnerability. For instance, recent evidence supporting the
inclusion of cognitive impairment within the CHS frailty model demonstrates that the biological
syndrome model of frailty is strongly correlated with criteria beyond those currently used (68).
Consistent with previous research, we found that women were more likely than men to be
classified as likely frail or depressed (46, 54, 55). Conditional item responses and class
characteristics were similar across gender-specific analyses, suggesting that classes had similar
meaning for men and women, and that gender differences are primarily due to the proportion of
individuals in each class. We did not find that a substantially greater proportion of women
belonged to a somatic depression class, in contrast to previous research (56). Instead, women
were twice as likely as men to be classified in the severe (10.4 vs. 5.7%) or moderate (13.3 vs.
6.8%) depression classes. Most previous studies regarding gender differences in somatic
depression have used samples of younger adults (69-71), and thus differences between our
findings and these prior studies may suggest that gender differences in the features of depression
decrease with age. However, longitudinal data is needed to examine this hypothesis more
directly.
Our findings should be interpreted in light of study limitations. First, while the CESD-8
asks respondents to report depressive symptoms in the previous week, some frailty criteria
describe changes (e.g., weight loss) or represent average measures (e.g. physical activity). These
differences in symptom time scale may have inflated the concurrence of depression and frailty
syndromes; however, these results are consistent with prior work using the DIS in which the time
scale of depressive symptoms was over a 6-month, rather than 1 week, period, and thus we
believe our findings are not substantially influenced by differences in symptom time scale.
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Second, the resulting classes from LCA are dependent on the specific metrics used to
operationalize frailty and depression syndromes. The CESD-8, a short symptom inventory, may
not evaluate all the depressive symptoms that are relevant to identify all meaningful classes. Our
results are, however, consistent with previous studies using the DIS, a fully-structured interview.
Strengths of this study include the large, nationally representative sample and use of LCA to
empirically determine syndrome classes, rather than relying on a priori cut-points to define
frailty and depression. With the large sample size, we were also able to examine whether gender
differences in the prevalence of depression and frailty were due to measurement inconsistencies.
Our study demonstrates that common epidemiologic instruments for measuring frailty
and depression identify highly overlapping subgroups of affected individuals among both men
and women. These findings have implications for the epidemiologic study of the predictors and
consequences of frailty in late life, as well as the translation of research on this construct into
clinical care. Future research should examine whether the co-occurrence of depression and frailty
is due to a shared pathology, and whether this comorbidity has implications for poor health
outcomes, including risk of disability, institutionalization, and mortality.
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Table 2.1. Weighted sample characteristics by depression status and sex

Overall

Elevated
Depressive
Symptomsa

Non-Elevated
Depressive
Symptoms

(N = 3665)

(N = 403)

(N = 3262)

Women

Men

(N=2,093)

(N=1,572)

b

Weighted % or Mean (SD)
Demographics
Female
Race
White
Black
Other
Age (years)

55.52

67.01

54.03

---

---

90.77
6.21
3.02
74.69 (0.14)

88.26
7.4
4.33
75.07 (0.45)

91.1
6.06
2.85
74.64 (0.15)

89.84
7.06
3.09
75.22 (0.19)

91.92
5.15
2.92
74.04 (0.20)

Education (years)
Married
Currently Employed (PT/FT)

12.63 (0.05)
56.02
10.18

11.33 (0.17)
41.82
6.83

12.8 (0.06)
57.85
10.61

12.39 (0.07)
41.91
7.49

12.93 (0.09)
73.63
13.53

15.95
12.44
14.91

27.63
32.09
40.41

14.43
9.9
11.62

16.1
13.57
15.63

15.75
11.02
14.02

25.78

63.46
---

20.91
---

25.65
13.81

25.94
8.49

6.71
15.91

9.07
46.42

6.41
11.97

8.28
18.7

4.76
12.43

Health Indicators
TICS (≤ 8 correct items)
Any IADL disability
Any ADL disability
Self-rated health (poor/fair)
CES-D ≥ 4 Symptoms
Frailty Criteria (present)
Low BMI
Exhaustion
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Slow movement
Weakness
Low energy
expenditure
Intermediate frailc
Frailc

30.92
27.46

48.80
39.01

28.61
25.97

35.86
29.72

24.76
24.64

21.91

40.95

19.44

23.66

19.71

45.83
12.35

47.85
32.91

45.57
9.62

47.46
15.47

43.79
8.46

a

Observations are weighted according to HRS physical measures sample weight
Elevated depressive symptoms are defined as ≥ 4 symptoms on the CESD-8.
c
Based on Fried et al. (2001) criteria. Subjects classified as frail if they endorsed 3 or more symptoms and intermediately frail
if endorsing 1 or 2 criteria.
b
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Table 2.2. Model fit indices from selected latent class models overall and by gender
Two latent variable models
Model 1:
Single latent
variable with
2 classes

Model 2:
Depression 3
class; Frail 3
class

Model 3:
Depression 3
class; Frail 4
class

Model 4:
Depression 4
class; Frail 3
class

Model 5:
Depression 4
class; Frail 4
class

Model 6:
Depression 5
class; Frail 4
class

37310.46
37478.04
37392.24

36319.13
36610.83
36461.49

36269.19
36610.55
36435.79

36044.04
36404.02
36219.73

35993.64
36409.48
36226.59

36035.86
36526.19
36275.16

Women
AIC
BIC

23090.75
23243.20

22443.18
22708.56

22411.57
22722.12

22246.76
22574.25

22204.59
22582.89

22162.38
22608.44

BICN

23157.42

22559.24

22547.38

22389.98

22390.03

22397.45

Model Fit Statistics
AIC
BIC
BICN

Men
AIC
14201.17
13865.67
13851.27
13796.71
13771.33
13810.95
BIC
14345.90
14117.60
14146.07
14155.83
14194.78
14121.83
BICN
14260.12
13968.29
13971.35
13942.99
13943.81
13937.58
AIC: Akaike Information Criterion; BIC: Bayesian Information criterion; BICN: sample-size adjusted BIC; Smaller values
indicate better model fit
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Table 2.3. Overlap of class proportions from joint model of depression and
frailty (Table 2.2, Model 4)
Total

Women

Men

3,665

2,093

1,572

66.5%

61.0%

75.0%

Not frail

88.0%

89.6%

88.0%

Moderate Frail

12.0%

10.4%

12.0%

Frail w/exhaustion

0.0%

0.0%

0.0%

11.2%

13.3%

6.8%

Not frail

57.8%

58.7%

80.5%

Moderate Frail

37.5%

38.6%

11.5%

Frail w/exhaustion

4.7%

2.7%

8.0%

13.7%

15.3%

12.5%

Not frail

14.9%

16.6%

11.4%

Moderate Frail

23.0%

27.4%

21.6%

Frail w/exhaustion

62.1%

56.0%

67.0%

8.6%

10.4%

5.7%

Not frail

27.1%

20.6%

44.4%

Moderate Frail

2.8%

7.2%

0.0%

Frail w/exhaustion

70.1%

72.2%

57.6%

Depressive symptom class
Frailty class
Low

Moderate

Somatic

Severe
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Figure 2.1. Conceptual model of correlated latent constructs – frailty and depression

Depressive symptoms include presence of the following symptoms much of the time within
the past week: 1) felt depressed, 2) enjoyed life (reverse coded), 3) felt lonely, 4) experienced
restless sleep, 5) felt happy (reverse coded), 6) felt sad, 7) felt everything was an effort, and
8) could not get going.

26

Figure 2.2a. Depressive class proportions and conditional probabilities of symptom endorsement

Figure 2.2b. Frailty class proportions and conditional probabilities of symptom endorsement

Conditional probabilities and class proportions estimated from the joint modeling of
depression and frailty (Table 3.2, Model 4).
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Chapter 3: Depression and Frailty in Late Life: Evidence for a Common
Vulnerability
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ABSTRACT
Objectives: The purpose of this study is to estimate the correlation between depression and
competing models of frailty syndrome and to determine to what degree the comorbidity of these
syndromes is determined by shared symptomology.
Methods: Data come from the 2010 Health and Retirement Study. Analysis was limited to
community-dwelling participants 65 and older (N=3,453). Depressive symptoms were indexed
by the 8-item Centers for Epidemiologic Studies Depression (CESD) scale. Frailty was indexed
by three alternative conceptual models: 1) biological syndrome, 2) cumulative medical burden,
and 3) functional domains. Confirmatory factor analysis (CFA) was used to estimate the
correlation between depression and each model of frailty.
Results: Each of the three frailty latent factors was significantly correlated with depression:
biological syndrome (ρ = .67, p <.01); functional domains (ρ = .70, p <.01); and cumulative
medical burden (ρ = .62, p <.01). Substantial correlation remained when accounting for shared
symptoms between depression and the biological syndrome (ρ = .43) and medical burdens (ρ =
.55) models.
Discussion: Results indicate that the correlation of frailty and depression in late life is
substantial. The association between the two constructs cannot be fully explained by symptom
overlap, suggesting that a shared liability to both syndromes may determine their frequent
comorbidity.
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INTRODUCTION
Aging is often accompanied by declines and deficits in multiple bodily systems. When
deficits are significant or numerous enough, physiological reserve may be compromised,
rendering older adults vulnerable to adverse health outcomes as a result of stressors or minor
perturbations to physical health (5). Frailty syndrome is considered to be a marker of such
vulnerability. Frailty is associated with higher incidence of adverse health outcomes such as
falls, hospitalizations and mortality (16, 49, 72), and may be an important predictor of
complications from surgery, medication use, and other common interventions (11-14). The
prevalence of frailty in community-dwelling older adult populations is approximately 11%;
however this estimate varies considerably depending on how frailty is defined, with estimates
ranging from 4% to 59% (46). Among those age 85 and older, the estimated prevalence of frailty
is approximately 26% to 44% (49, 54). The wide ranges reflect fundamental conceptual
disagreements regarding the operationalization of this syndrome. These estimates also suggest
that frailty, while common, is not an inevitable consequence of advanced age, leading to
speculation about how it might be prevented or how it might inform health-related decisions and
interventions.
Despite promise as a tool for prevention, frailty’s utility remains limited by conceptual
and operational differences. Though there is implicit agreement that frailty is a condition
conferring vulnerability, diverging explanations of how to define frailty result in substantially
different empirical answers to the question “Who is frail?”. In a community-based sample of
older adults, Cigolle and colleagues compared the diagnostic overlap of three frailty models
representing three distinct conceptual approaches: 1) a biological syndrome model comprised of
five specific physiological symptoms (49), 2) a cumulative medical burden index, characterizing
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frailty as a state produced by accumulated medical burdens (72), and 3) a functional domains
model, emphasizing deficits in specific functional abilities (24). Of the older adults found to be
frail by at least one model, only 44% were designated as frail by at least two models and only
10% by all three (48). The clear conceptual and diagnostic discordance between frailty models
highlights uncertainty regarding the features that should be used to define it. Consequently, a
range of potential symptoms, including physiological, cognitive, psychiatric, and sensory deficits
have been incorporated into extant frailty definitions (19, 26, 68).
Another challenge to defining frailty is distinguishing it from other common conditions
of later life, particularly depression. Like frailty, depression among older adults has been
described in terms of diminished reserve capacity, representing a lack of coping resources to
respond to mental or physical stressors (32, 73). For example, de Jonge and colleagues
hypothesized that poor adjustment following somatic insult among depressed older adults may
reflect inadequate psychological and social coping mechanisms, referring to depression as a form
of “psychosocial frailty” (74). Depression and frailty are associated with similar outcomes, have
similar risk factors, and, depending on the definition of frailty, share similar sympotomology (32,
33). The two concepts are likewise difficult to disentangle in operational terms. Our previous
work has shown that frailty and depression produced highly overlapping classification of
afflicted individuals, even when correcting for chance categorical overlap (40, 75).
The operational discrimination of frailty and depression is of both conceptual and
practical concern. First, the validity of a measurement instrument is tied to its ability to
discriminate distinct conditions from one another (76). The inability of frailty models to
discriminate between frail and depressed individuals would indicate that current models are poor
at measuring construct differences or, alternatively, that distinction between these constructs is
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unwarranted. Second, treatment and prevention approaches for vulnerable older adults would
differ based on the putative underlying nature of vulnerability, whether it is primarily
psychological, physiological, or both. For example, adherence and pharmacodynamic response to
anti-depressant medications may be worse among frail older adults (43, 44). When frailty and
depression are comorbid, multimodal interventions targeting both depressive illness and
physiological deficits concurrently would potentially be more effective than focus on a single
area (45).
Arguably, the comorbidity of frailty and depression is similar to the comorbidity
between common mental disorders (e.g. depression and anxiety) and presents similar challenges
to research design. In epidemiologic studies of frailty, typical strategies for addressing this
comorbidity are: 1) excluding individuals who meet criteria for depression, or 2) including
individuals without regard for comorbid depression. Both strategies are problematic and may
potentially lead to incorrect inferences regarding frailty and depression (77, 78). For instance,
excluding depressed individuals from a study of frailty would yield a sample of frail individuals
who are non-representative of frail older adults and, importantly, who are less severely impaired
(77, 79). On the other hand, ignoring comorbidity in this context would make it difficult to
distinguish whether outcomes were related to frailty, depression or the interaction of the two (7779). As the validity of frailty models is often tied to model prediction of outcomes like falls,
hospitalization and mortality (21, 49), this problem would conceivably impact the comparative
effectiveness of alternative frailty definitions.
Reflecting these limitations in the extant literature, in this study we aim to determine the
correlation between depression and frailty conceived as latent dimensional factors using
confirmatory factor analysis (CFA). By using a dimensional approach, we address limitations
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introduced by viewing frailty and depression as dichotomous or categorical conditions. Instead,
frailty and depression are conceived as extreme points on continua of physical and psychological
functioning. Substantial correlation between the two constructs is indicative of a higher order
factor (or liability) which influences likelihood of both frailty and depression. Such a finding
would provide clarity to the discussion of comorbidity and would help inform future attempts to
refine the definition of frailty. To investigate whether operational differences play a role in the
relationship between frailty and depression, separate analyses will be performed for each of the
three frailty models identified by Cigolle and colleagues. We expect that the correlation of frailty
and depression will be substantial but will vary considerably based on different specifications of
frailty criteria.
METHODS
SAMPLE
This study is based on data from the 2010 wave of the Health and Retirement Study
(HRS), a prospective survey of older adults begun in 1992, designed to collect longitudinal
information on the health and finances of older Americans. The HRS employs a multi-stage
probability sample of US households to produce a nationally-representative sample of adults age
51 or over (57). Self-reported information regarding demographics, chronic health conditions,
daily activities, disability status, health insurance and other determinants of health are collected
at baseline and at subsequent two-year intervals. Beginning in 2004, a randomly-selected subset
of HRS respondents participated in enhanced face-to-face interviews which included objective
assessment of walking speed, hand strength, weight, height and other physical measures (58).
Respondents aged 65 or older at the time of interview were considered eligible for the
study. Respondents were considered ineligible if they were interviewed via a proxy or if they
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resided in a nursing home at the time of interview. The primary analytical sample was restricted
to respondents who were selected for the enhanced face-to-face interviews and completed or
attempted physical measures tasks (grip strength and walking speed) used in the calculation of
frailty scores. Sensitivity analyses were conducted to evaluate potential influence of excluding
individuals with missing physical measures data.
The HRS is approved by the Institutional Review Board (IRB) at the University of
Michigan, and this analysis received exempt status from the IRB at Virginia Commonwealth
University. All participants provided informed consent.
MEASURES
Frailty
Biological Syndrome
The biological syndrome model of frailty was operationalized using five criteria proposed
by Fried and colleagues in the Cardiovascular Health Study (CHS): low weight, physical
inactivity, exhaustion, weakness, and slowness (49). Low weight was defined as a loss of 10% or
more in BMI since the previous (2008) wave or a current BMI <18.5 kg/m2. Physical activity
was calculated as the average frequency of three activity intensities weighted by average
metabolic equivalency of task (MET) scores: mild (1-3 MET), moderate (3-6 MET), and
vigorous (6-10 MET). Participants were considered physically inactive if they scored in the
lowest 20% of average physical activity. Exhaustion was specified in two ways: 1) using items
from the Center for Epidemiologic Studies – Depression (CESD), as in the original CHS
operationalization, and 2) as self-reported persistent or troublesome fatigue or exhaustion within
the past two years. The separate specifications of exhaustion were compared to assess the role of
shared criteria in the overlap of biological syndrome frailty and depression. Weakness was
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assessed using the average of two measurements of dominant hand grip strength as measured by
dynamometer. Weakness was defined as strength below BMI- and gender-specific thresholds
established in the CHS. Slowness was defined as having a walking speed measured over a 2.5meter distance below gender- and height-specific cut-points established in the CHS (49).
Participants were considered as meeting criteria for weakness or slowness if they attempted the
corresponding physical measures but were unable to complete due to physical limitation.
Participants who did not attempt physical measures due to lack of appropriate facilities or
equipment or recent surgery were considered as missing on these physical measures.
Frailty Index
As originally conceived, the Medical Burdens Frailty Index (FI) is a count of 70 clinical
deficits, including presence of diseases, difficulties in daily activities, and other physical and
neurological signs and symptoms (72). A FI score is calculated as the ratio of present deficits to
total possible deficits (e.g. FI = 20/70 = .29). Subsequent analyses have demonstrated that frailty
indices composed of 30 – 40 deficits have comparable predictive validity to the full index when
deficits are selected based on pre-determined criteria (80, 81). Selection criteria for deficit
inclusion are: 1) a deficit must generally accumulate with age, 2) a deficit must be related to
health status in a biologically plausible way, 3) a deficit must not become saturated (i.e.
universally prevalent) at an early age, and 4) the deficits together must represent a range of
bodily systems (80). Using variables available in the HRS, the current study reproduced 35 of the
original 70 deficits satisfying these selection criteria (Appendix 3.1). Although presence of
depression may itself be considered an indicator in the FI, self-reported and study-determined
depression diagnosis was excluded as an indicator in this study in order to address key study
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questions of syndrome correlation. Each deficit was considered as either present (1) or absent (0)
and no variable contained more than 5% missing cases within the analytic sample.
Functional domains
Strawbridge and colleagues define frailty as functional impairment in at least two of four
domains: physical, nutritive, cognitive and sensory (24). In the current study, impairment in each
domain was designated as present (1) or absent (0) according to operational criteria defined by
Cigolle and colleagues using HRS data (48). Impairment in physical functioning was defined as
having persistent dizziness or lightheadedness, experiencing at least one fall in the prior two
years, or having difficulty lifting or carrying weights over 10 pounds. Impairment in nutritive
functioning was defined as a loss of 10% or more in BMI since the previous (2008) wave or a
current BMI <18.5 kg/m2. Cognitive functioning was assessed using a 35-point composite
measure of mental status, reasoning and memory task performance developed in the HRS (62,
82). Impairment in cognitive functioning was defined as a score of 10 or less (corresponding
with lowest 10% of HRS respondents) on the HRS cognitive performance measure. Sensory
impairment was defined as having fair/poor self-rated vision despite use of corrective lenses or
fair/poor hearing despite use of a hearing aid.
Depressive Symptoms
Current depressive symptoms (referred to hereafter as “depression”) were measured using
the 8-item Center for Epidemiological Studies–Depression scale (CESD) (59). Respondents are
asked to indicate whether they have experienced any of the following symptoms much of the
time during the previous week: 1) felt depressed, 2) felt activities were efforts, 3) had restless
sleep, 4) felt happy, 5) felt lonely, 6) enjoyed life, 7) felt sad, 8) felt unmotivated. Positive
symptoms (i.e. feeling happy and enjoying life) were reverse-coded. Although the CESD is not
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intended to be a diagnostic tool for major depression, it has been shown to have moderate
agreement with the Composite International Diagnostic Interview (CIDI), a structured instrument
for assessment of major depression (59, 60).
Sociodemoographic Covariates
Other variables included in the analysis were sex (male=0; female=1), race (dummy
variables for white, black, and other), years of education (12 or more years=0; fewer than 12
years=1), primary health insurance provider (dummy variables indicating private, Medicare, and
Medicaid insurance), marital status (dummy variables for currently married/partnered,
separated/divorced/never married, and widowed), and household poverty-to-income ratio
(0=above poverty threshold; below poverty threshold=1). Age was treated as a continuous
variable or in 10-year categories (65-75 years, 75-85 years, and greater than 85 years).
ANALYSIS
First, exploratory factor analyses (EFA) were performed for each of the latent constructs
(three frailty models: biological syndrome, medical burden frailty index, and functional domains,
and depression) separately to determine whether the factors, as specified, represented unidimensional constructs.
Figure 3.1a – c illustrates the confirmatory factory analysis (CFA) models used to
evaluate the correlations between depression and frailty. CFA is an appropriate method for
assessing correlation between latent factors that are not directly observable and which are
imperfectly measured by the presence of observable symptoms (83). In CFA, constraints are
imposed a priori on the number of latent factors, the variables used to indicate the factors, and
the relationships between variables in the model (83, 84). In CFA latent factors are conceived as
dimensional traits, existing on a continuum rather than as categorical diagnoses. In the current
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study, indicators of the latent frailty factor were determined by the dichotomous symptoms from
each of the three models described above, while depression was indicated by items from the
CESD. Two types of CFA model were fit to the data: 1) single-factor models in which a single
latent factor was indicated by both frailty items and depression items from the CESD (Figure
3.1a); 2) correlated two-factor models in which separate frailty and depression factors were each
defined by their respective indicator variables (Figure 3.1b). In cases where frailty and
depression share symptoms by definition (i.e., the symptom “exhaustion” in the biological
syndrome model of frailty, as described above), indicator variables were allowed to cross-load
on each factor (Figure 3.1c). Models allowing cross-factor loading were compared with models
in which shared symptoms indicated only depression in order to evaluate the role of shared
symptoms in the correlation between frailty and depression.
The influence of sociodemographic characteristics on latent factors was estimated using
multiple indicator, multiple cause (MIMIC) structural equation models. MIMIC models allow for
estimation of the influence of covariate characteristics such as age, sex, and race on latent
variables. MIMIC models contain at least two components: 1) a measurement component
relating the indicator symptoms to the latent variables of frailty and depression (equivalent to
CFA models), and 2) a regression component, regressing latent variables on the covariates
(Figure 3.2a). When the correlation between frailty and depression was high (that is > 0.60),
correlated factor models were equivalently re-expressed as second-order factor models in which
a higher order factor is postulated to explain the correlation between frailty and depression.
MIMIC models were used in these cases to estimate the influence of covariate factors on the
second-order ‘vulnerability’ factor, indicated by frailty and depression sub-factors (Figure 3.2b).
Model Estimation
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Models were estimated using weighted least squares means and variance adjusted
(WLSMV) and full-information maximum-likelihood (MLR) estimators as implemented in
Mplus software for categorical variables. MLR estimation was used in models which included
data from participants who were missing physical measures data, under a missing at random
(MAR) assumption. Model fit was assessed using standard fit criteria: Comparative Fit Index
(CFI), Tucker-Lewis Index (TLI), and root mean square error of approximation (RMSEA). As
recommended in previous research, pre-specified values of CFI >.90, TLI >.90, and RMSEA
<.06 were taken to indicate adequate model fit (85).
Analyses were performed using MPlus (Version 7) and all p-values refer to two-tailed
tests.

RESULTS
Sample Characteristics
Figure 3.3 illustrates the selection of the analytic sample. A total of 22,034 respondents
participated in the 2010 HRS wave of whom 10,938 were 65 or older at the time of interview and
were considered eligible for the study; 1,211 respondents were excluded because they were
interviewed by proxy or resided in a nursing home. Of the community-dwelling, non-proxy
respondents, 4,035 were selected for and consented to enhanced face-to-face interviews and
physical measures. The primary analytical sample was restricted to 3,453 respondents who
completed or attempted physical measures tasks (grip strength and walking speed). Primary
reasons for incomplete physical measures were absence of a suitable space for testing (N=137),
recent surgery or health condition preventing testing (N=98), and respondent thinking the task
would not be safe (N=128).
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Table 3.1 shows the demographic and health characteristics of the analytic sample.
Participants with a self-reported history of depression were more likely to be female, white, to
have a household income below the poverty threshold, and to be Medicaid beneficiaries.
Participants with a history of depression were significantly more likely to be frail according to
diagnostic criteria proposed by the original authors of each of the three frailty models.
Comparing individuals with a history of depression to those without, the odds of being
considered frail at the time of interview were approximately twice as high according to the
biological syndrome and functional domains models. According to the medical burdens FI
model, the odds of being frail at time of interview were approximately four times as high for
those with a history of depression.
CFA models of depression and frailty
CFA models of the individual latent frailty variables as uni-dimensional factors produced
good fit to the data, with all model fit indices satisfying pre-specified criteria (Appendix 3.2).
Results using only data from the analytic sample (N=3,453) were similar to those using data for
individuals with missing data under MLR estimation (N=4,035), and so only results from the
analytic sample are reported (data not shown
Results from CFA models of depression and the three models of frailty are shown in
Table 3.2. When depression and frailty were conceived as a single latent factor (indicated by
symptoms of both depression and frailty), the biological syndrome and functional domains
definitions fit the data adequately, while the medical burdens frailty index fit the data poorly
according to pre-specified model fit criteria. Correlated two-factor models provided better fit to
the data than single factor models according to all three definitions; however, fit indices
indicated poor fit overall for the medical burdens frailty index definition. Correlation between

40

frailty and depression latent variables was substantial for each of the three frailty definitions with
correlations of 0.67 (95% CI: 0.63 - 0.71) for the biological syndrome, 0.61 (95% CI: 0.59 0.63) for the frailty index, and .70 (95% CI: 0.66 - 0.74) for the functional domains definitions.
Because the biological syndrome and medical burdens frailty index models share items
with the CESD (i.e., exhaustion), a third set of CFA models was estimated allowing crossloading of items to indicate both frailty and depression factors. Allowing shared symptoms to
cross-load on both frailty and depression significantly improved the fit of both models.
Correlation between frailty and depression decreased in the shared-symptom models for the
biological syndrome (from .67 to .43) and for the frailty index (from .61 to 56) definitions,
suggesting that shared symptoms determine some, but not all of, the correlation between the
constructs.
MIMIC models
The size of correlations between depression and the three frailty models suggested that
frailty and depression could be instead specified as sub-factors of a higher order “vulnerability”
latent factor. To further explore the influence of sociodemographic covariates on the correlation
between frailty and depression, MIMIC models were fit to estimate the influence of
sociodemographic covariates on the hypothesized higher order latent factor. Regression
coefficients from MIMIC models are displayed in Table 3.3. Compared to men, women had
significantly higher average factor level for each of the three frailty definitions (Biologic
Syndrome: β = 0.12, 95% Confidence Interval (CI) 0.09 – 0.15; Medical burdens: β = 0.17, 95%
CI 0.13 – 0.20; Functional domains: β = 0.09, 95% CI 0.06 – 0.12). Likewise, older age, lower
education, not being married, having a household income below the poverty threshold, and being
a Medicaid beneficiary were associated with higher levels of the second order latent factors for
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each frailty definition. The influence of coefficients on the higher order latent factor suggest that
these covariates predict greater levels of frailty, depression, and comorbid disorder. No
significant differences in factor level were found among different races or among widows.

DISCUSSION
This study examined the correlation between frailty and depression using three
conceptually distinct definitions of frailty and a latent variable approach. Regardless of
definition, frailty was substantially associated with depression, with correlation coefficients
ranging from 0.61 to 0.70 in two-factor models. When accounting for the influence of shared
symptomology and covariate predictors of the latent variables, correlation remained substantial.
These results suggested the existence of a second-order “vulnerability” factor which influences
levels of both frailty and depression. Our findings provide evidence that frailty and depression,
as commonly defined in epidemiologic research, are not only associated concepts, but may be
expressions of a shared underlying vulnerability construct. This underlying construct, which
subsumes physiological, functional, and psychological aspects of vulnerability, provides a
sensible organizational structure to explain the frequent comorbidity of frailty and depression in
the population.
These findings should be interpreted in light of study strengths and limitations. First, the
HRS is among the largest, most well-characterized samples of older adults in existence. Because
of the breadth of this data source we were able to operationalize and compare multiple
definitions of frailty. This study is among the first, to our knowledge, to investigate the
association between depression and multiple models of frailty using a common data source.
Consistency of results across multiple definitions of frailty indicates that our inferences
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regarding the nature of the relationship between depression and frailty are analytically and
conceptually robust. Also, we explicitly accounted for the measurement error inherent in the
study of syndromes like depression and frailty using latent variable modeling. This approach is
important in the analysis of the discriminant properties of frailty for which there is no consensus
definition.
We also note study limitations. First, our operationalizations of frailty were approximate,
but not exact replications, of the measurement schema proposed by their original developers.
Although care was taken to reproduce the elements of each definition as closely as possible, the
extent to which the indicators do not capture the intended construct may introduce error in the
results. Nevertheless, these operationalizations of frailty have been successfully applied in past
studies of frailty in the HRS and were found to be consistent with the original definitions (48).
Second, the analytic sample was restricted to those who were selected for and completed
physical measures. While the physical measures subsample was selected at random from the
HRS population, missing data on these measures may introduce bias. However, we believe this
bias is minimal because models estimated using ML which included all participants eligible for
physical measures regardless of missing values (N=4,035) produced similar results to models
using only the analytic sample. Lastly, the measure of depression used in this study, the CESD, is
not designed to approximate clinician diagnosis of major depression but is, rather, a catalog of
current depressive symptoms. The extent to which the CESD does not capture the underlying
construct of depression may have biased the results of the study; however, the CESD is among
the most widely used scales for the measurement of depressive symptoms in epidemiologic
research, and therefore its association with frailty has significance for research. Furthermore, the
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CESD has been shown to produce moderate diagnostic agreement with more structured
instruments for the assessment of major depression such as the CIDI (59, 60).
This study provides valuable insights into the measurement and definition of frailty and
helps to synthesize disconnected lines of research in gerontology and psychiatry. One key
finding is that the strong correlation exhibited between frailty and depression is not unique to a
single definition of frailty and cannot be fully explained by shared symptomology. Indeed, the
functional domains model, which shares no symptoms with the CESD, was the most highly
correlated with depression. While model comparisons indicate that frailty and depression are
distinct syndromes, the consistency of the relationship between these two constructs suggests the
possible role of shared underlying vulnerability processes in determining frailty, depression and
their comorbidity. Consistent with this hypothesis, studies have suggested that vascular disease
and vascular ageing are important predictors in the development of frailty, sarcopenia, and other
geriatric syndromes (67, 86, 87). The plausibility of this hypothesis is supported by findings that
angiotensin-converting enzyme inhibitors, medications typically used in the treatment of
hypertension and congestive heart failure, may help to prevent or slow decline in physical
function and muscle strength (9, 10). Likewise, cerebrovascular diseases, particularly those
leading to subcortical ischemic lesions, are thought to cause or to facilitate the expression of
depression in late life (88). The specific nature of the underlying vulnerability processes
proposed in this study remains to be explored.
We note that alternative explanations of comorbidity between depression and frailty can
also not be excluded. For instance, frailty and depression may be related through causal
mechanisms, or vascular depression may be a prodromal state of frailty (38). However, the
hypothesized processes determining comorbidity of frailty and depression provide a target for
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future research and serve to merge and organize evidence from studies of frailty and late-life
depression.
Although this comorbidity can be viewed as a methodological nuisance to be avoided or
addressed in studies aimed at predicting disability and decline, the confluence of frailty and
depression may have important clinical implications. For instance, recent studies have
demonstrated that frail older adults with depression have higher risk of mortality than nondepressed frail elders, suggesting that depression may exacerbate or hasten the development of
frailty symptoms (45). Individuals with both frailty and depression may thus benefit from more
comprehensive interventions that assess and target both frailty and depressive symptoms, for
instance, by combining anti-depressant treatment with exercise and nutritional interventions (45).
Likewise, frailty status may be an important consideration in choosing between treatment options
for depression, as some therapies may increase risk of falls among vulnerable older adults.
In conclusion, our results demonstrated a significant and consistent correlation between frailty
and depression among older adults, which is not be fully explained by definitional differences,
symptom overlap, or sociodemographic covariates. Given that comorbidity of physical and
mental disorders is common in late life, future research should continue to explore reasons for
comorbidity and the combined implications of frailty and depression in predicting adverse health
outcomes among older adults.
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Table 3.1. Sample characteristics by lifetime history of depression
Overall

Lifetime
Depression

(n=3,453)

(n=462)

No
Lifetime
Depression
(n=2,991)

p-Value

% or Mean (sd)
Demographics
Age (yrs)
Female
Race
White
Black
Other
Education (>12 yrs)
Household Poverty
Marital Status
Married/partnered
Separated/divorced
Widowed
Health Insurance
Medicare
Medicaid
Private
Frailty

75.0 (6.8)
56.2

73.5 (6.5)
72.9

75.2 (6.8)
53.6

<.001
<.001
0.051

84.7
11.9
3.4

88.3
8.7
3.0

84.1
12.4
3.4

43.7
7.6

42.2
10.4

43.9
7.1

64.1
11.6
24.3

52.0
15.4
32.7

66.0
11.1
23.0

96.8
6.0
24.7

97.4
9.2
22.2

96.7
5.5
25.1

0.568
0.004
0.182

11.7
53.2

20.8
58.7

10.3
52.4

<.001

25.4
27.7

51.7
27.3

21.3
27.7

<.001

22.2
38.3

35.7
42.0

20.4
37.7

<.001

0.512
0.018
<.001

Biological syndrome1
Frail
Intermediate
Frailty Index2
Frail
Intermediate
Funtional domains3
Frail
Intermediate
1

Biological syndrome: frail = 3 or more symptoms; intermediate = 1 or 2
symptoms
2
Frailty index: frail = index score >.25; intermediate = index score >.15
3
Functional domains: frail = 2 or more symptoms; intermediate = 1 symptom
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Table 3.2. Model fit statistics and latent variable correlations
Frailty definition
Frailty
index

Functional
domains

0.836
0.828
0.051

0.957
0.947
0.055

Frailty and depression as separate but correlated latent factors
CFI
0.944
0.854
TLI
0.959
0.909
RMSEA
0.054
0.049

0.952
0.962
0.053

Biological
syndrome
Frailty and depression as single factor
CFI
0.950
TLI
0.940
RMSEA
0.054

Correlation w/depression
95% CI

0.67
(0.63 - 0.71)

Correlation accounting for shared symptoms
CFI
0.980
TLI
0.974
RMSEA
0.038

0.61
(.59 - 0.63)

0.70
(.66 - .74)

0.933
0.929
0.041

-------

Correlation w/depression
--0.43
0.56
95% CI
--(0.37 - 0.49)
(.54 - .58)
1
For the biological syndrome definition, shared symptoms were items for not feeling
motivated and feeling activities were an effort from the CESD
2
For the frailty index, the shared symptom from the CESD was feeling depressed much of
the time in the past week
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Table 3.3. MIMIC model regression coefficients of covariate influence on second-order latent variables

Biological syndrome
Estimate
95% CI
Characteristics
Female
Age
65-75
75-85
85 or greater
Race
White
Black
Other
Marital Status
Married
Separated/divorced
Widowed
Education < 12 years
Income (below poverty
threshold)
Health Insurance
Medicaid
Medicare
Private insurance

Frailty definition
Frailty index
Estimate
95% CI

Functional domains
Estimate
95% CI

0.12

(0.09, 0.15)

0.17

(0.13, 0.20)

0.09

(0.06, 0.12)

--0.08
0.17

--(0.05, 0.11)
(0.12, 0.22)

--0.15
0.39

--(0.11, 0.19)
(0.33, 0.45)

--0.08
0.21

--(0.05, 0.11)
(0.16, 0.26)

---0.01
0.07

--(-0.05, 0.03)
(-0.01, 0.14)

---0.02
0.00

--(-0.07, 0.03)
(-0.09, 0.09)

--0.01
0.07

--(-0.03, 0.04)
(-0.01, 0.15)

--0.17
0.01
0.24

--(0.12, .22)
(-0.04, 0.06)
(0.20, 0.28)

--0.19
0.01
0.32

--(0.13, 0.25)
(-0.05, 0.07)
(0.28, 0.36)

--0.14
0.02
0.26

--(0.10, 0.18)
(-0.02, 0.06)
(0.22, 0.30)

0.13

(0.08, 0.18)

0.15

(0.11, 0.19)

0.16

(0.11, 0.21)

0.20
-0.01
-0.01

(0.14, 0.26)
(-0.09, 0.07)
(-0.04, 0.03)

0.34
0.05
-0.02

(0.28, 0.41)
(-0.05, 0.15)
(-0.06, 0.03)

0.19
0.00
-0.03

(0.14, 0.24)
(-0.07, 0.07)
(-0.06, 0.01)
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Figure 3.1a. Single latent factor model of frailty and depressive symptoms

Symptoms of frailty and depression indicate a single latent factor implying that a single
underlying condition explains variance among both frailty and depressive symptoms.
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Figure 3.1b. Two-factor model without symptom overlap
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Figure 3.1c. Two-factor model assuming shared symptoms and cross loading
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Figure 3.2a. Example of MIMIC model adjusting for sociodemographic covariates
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Figure 3.2b. Example of MIMIC model with second-order latent factor

Note: Similar models were fit for each of three frailty definitions. Not all covariates included in analyses
are depicted in figure.
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Figure 3.3. Sample inclusion/exclusion flowchart
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Chapter 4: Frailty, Adverse Health Outcomes and Influence of Depression: A
Latent Growth Curve Analysis
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ABSTRACT
Objectives: This study used latent growth curve modeling (LGCM) to estimate trajectories of
frailty and association between frailty trajectories and propensity for nursing home admission
and falls. The time-varying influence of depression on the association of frailty and adverse
health outcomes was also evaluated.
Methods: This study used data from five waves (2004-2012) of the Health and Retirement
Study. A total of 10,611 community-dwelling individuals age 55 and older who participated in
all waves were included in analysis. Frailty was measured using three alternative models: 1)
functional domains, 2) medical burdens, and 3) biological syndrome. Depressive symptoms were
measured using the 8-item Centers for Epidemiologic Studies Depression (CESD) scale. Adverse
health outcomes included any nursing home stay within the previous two years and or injury
from falls requiring medical treatment. Latent growth curves were used to estimate frailty
trajectories and propensity to experience adverse health outcomes.
Results: The proportion of participants considered frail increased over the study period, and
LGC models showed that average frailty trajectories were positive for all three frailty definitions
(Functional domains: β=.182, p<.001; Medical Burdens: β=.078, p<.001; Biological Syndrome:
β=.375, p<.001). Socio-demographic characteristics predicting steeper growth differed based on
frailty definition. Parallel growth process models showed that steeper increases in frailty were
associated with higher likelihood of both nursing home admission and serious falls (Functional
Domains: βNursingHome=.594, p<.001; βFall=1.759, p<.001; Medical Burdens: βNursingHome=.889,
p<.001; βFall=1.782, p<.001; Biological Syndrome: βNursingHome=.333, p<.001; βFall=1.306,
p<.001). However, these associations were attenuated, and in some cases were no longer
statistically significant, after accounting for depressive symptoms.
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Discussion: Developmental trajectories of frailty may be important indicators of risk for nursing
home admissions and falls, independent of baseline frailty status. Targeted interventions focused
on slowing development or progression of frailty symptoms may provide benefits in helping
older adults maintain functional independence. Future studies of frailty must account for
concurrent depression status as an important and highly correlated condition.
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INTRODUCTION
Epidemiologic studies indicate that frailty, a syndrome purported to represent
vulnerability to poor health outcomes, is common in late life. The likelihood of being frail
increases with age, with 10% of adults age 65 and older and over 30% of adults age 85 and older
considered frail (46). The prevalence of frailty varies considerably by sociodemographic
characteristics. Women, racial minorities, and individuals with less education have higher risk of
frailty (46, 89, 90). Epidemiologic evidence has linked frailty to higher risk of outcomes such as
falls, nursing home entry, hospitalization, and earlier mortality (49, 72, 91). Frailty has also been
used as a clinical measure to determine eligibility for treatment approaches such as surgery and
pharmacologic intervention (11-14).
Despite frequent use of frailty in epidemiologic and clinical research, there is no
consensus regarding its operationalization. Various competing conceptual and operational
models have emerged, yielding significantly different estimations of frailty (19, 48, 51, 92). At
least three conceptually distinct models have been used extensively in research literature: 1) a
biological syndrome model (49), 2) a medical burdens model (21), and 3) a functional domains
model (24). The biological syndrome and medical burdens models are the two most widely cited
and validated measures of frailty (26, 93); however, these three models offer conflicting views
regarding the underlying nature of the frailty construct. Whereas the biological syndrome model
conceives of frailty as a syndrome of five specific physiological symptoms, distinct from the
concept of comorbidity (18, 50), the medical burdens model posits that frailty is indexed as a
sum of accumulated disorders and deficits, similar to comorbidity (17, 81). While the functional
domains model is cited less frequently in the research literature, its focus on frailty as measured
by functional limitations provides a third distinct conceptual basis for measuring frailty (26). To
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varying degrees, each of the three frailty models has been validated in terms of their ability to
predict adverse health outcomes; however, few studies have compared the longitudinal
relationship of all three models to such outcomes (16, 21, 24, 49).
An important consideration in the study of frailty is its relationship to late-life depression.
Evidence from multiple fields suggests that frailty and depression are highly related, both as
comorbid conditions and as conceptually similar conditions (32, 33, 38, 42, 45). First, frailty and
depression share symptoms (i.e., weight loss, fatigue) and increase risk of similar adverse health
outcomes over time. For instance, both frailty and depression have been found to increase risk of
earlier mortality among older adults (49, 91, 94, 95). Second, common instruments used for case
ascertainment of frailty and depression lead to similar categorization of afflicted individuals. For
instance, previous work by our group has shown that operationalizations of frailty and depression
produce highly concordant estimates of individuals who are frail and depressed (40, 75). Lohman
et al. (Chapter 3) further showed that, when modeled as dimensional traits, depression and frailty
were substantially correlated after adjusting for sociodemographic covariates related to
prevalence of both conditions. Third, depression among older adults is often characterized by a
relative lack of mood symptoms and greater number of neurovegetative symptoms, in what has
been termed “depression without sadness” or “masked depression” (41, 96, 97). This alternate
presentation of depression among older adults may lead to further difficulties in discriminating
depression from frailty in late life. The substantial comorbidity and common symptomology
between frailty and depression indicate the need for approaches which incorporate rather than
exclude depression as a consideration in studies of frailty.
Frailty, like depression, is a dynamic condition in which symptoms may manifest and
remit over time (98). Accordingly, the risk of poor health outcomes conferred by frailty likely
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also changes over time. Despite this, research on frailty rarely accounts for temporal changes in
frailty status, instead focusing on whether an individual is categorized as frail or not frail at a
given point in time and whether this status predicts future outcomes (19, 21, 24, 47, 49). Failure
to account for temporal changes and dynamic nature of frailty may lead to incorrect inferences
about the frailty construct and its relationship with poor health.
There are two primary aims of the current study. First, we will use latent growth curve
models to estimate the trajectories of frailty using the three definitions (biological syndrome,
medical burdens, and functional domains) outlined above. We will assess whether these frailty
growth trajectories are associated with two adverse outcomes in later life: likelihood of nursing
home admission and likelihood of falling. Although previous research has linked baseline frailty
status with risk of future adverse health outcomes, to date none have assessed whether
trajectories of frailty are associated with the likelihood of experiencing adverse health events. As
part of this aim, conditional latent growth models will be used to determine whether frailty
trajectories are influenced by characteristics such as gender, race, and education. The second aim
is to determine the extent to which depression, treated as a time-varying covariate, influences the
relationship between frailty and adverse health outcomes. We expect that, given the strong
association between frailty and depression indicated by prior research, incorporation of
depression will substantially diminish the relationship between frailty and adverse health
outcomes.
METHODS
Data for the current investigation come from the Health and Retirement Study (HRS), an
ongoing household survey initiated in 1992 in order to study the health and financial dynamics of
older Americans. The HRS is a multi-stage area probability sample of household units designed
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to be representative of the non-institutionalized U.S. population of adults over the age of 50 (57).
New cohorts of participants are added every three waves (six years) in order to maintain the
steady-state and representativeness of the sample. The latest wave of interviews was completed
in 2012. The primary HRS questionnaire is administered by telephone at study entry and at
subsequent two-year intervals. The questionnaire asks respondents to report information
regarding demographics, health conditions, functional limitations, health insurance and other
determinants of health. Beginning in 2004, a random half-sample of HRS respondents was asked
to complete an enhanced face-to-face interview including objective physical measurements of
gait speed, strength, balance and other aspects of physical health (58). The enhanced face-to-face
interview was completed on the remaining half of the sample in alternate years.
The 2004 HRS wave had 19,750 respondents, of whom 66% (N=13,054) remained in the
study as of the 2012 wave. Respondents were selected for this analysis if they met several
selection criteria: first, participants were included in analysis if they were at least 55 years of age
in 2004 ensuring that all study participants would be 65 years or older during the last interview
wave. Since nursing home stay was a primary outcome of interest, participants were excluded
from analysis if they resided in a nursing home at the time of study entry (n=93) or if they were
interviewed via a proxy respondent (n=625). These selection criteria resulted in a final analytic
sample of N=10,611 respondents. Information for these respondents from waves 2004, 2006,
2008, 2010, and 2012 was used in the current study.
The HRS is approved by the Institutional Review Board (IRB) at the University of
Michigan, and this analysis received exempt status from the IRB at Virginia Commonwealth
University. All participants provided informed consent.
MEASURES
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Frailty
Biological Syndrome
Fried and colleagues define frailty as a biological syndrome represented by five specific
symptoms derived from the Cardiovascular Health Study (CHS): slow gait speed, muscle
weakness, low physical activity, exhaustion, and low of body weight (49). In the current study,
gait speed was measured by time to complete a 2.5-meter walking course and stratified by sex
and height. Slowness was defined according to sex- and height- specific cutoff values proposed
in the CHS (Appendix 4.1). Strength was defined as the average of two grip-strength
measurements of the respondent’s dominant hand by dynamometer. Weakness was defined as
grip strength below gender- and BMI- specific thresholds established in the CHS (Appendix 4.1).
Participants were considered as meeting criteria for weakness or slowness if they attempted the
corresponding physical measures but were unable to complete due to physical limitation.
Physical activity was measured as the average frequency of self-reported mild, moderate, and
vigorous activity weighted according to metabolic equivalency of task (MET) scores (Appendix
4.1). Participants in the lowest 20% of physical activity were considered to have low physical
activity. Exhaustion was defined as self-reported persistent or troublesome fatigue or exhaustion
within the past two years. Low weight was defined as a loss of 10% or more in BMI in the past
two years or a current BMI < 18.5 kg/m2. Participants were considered frail according to the
biological syndrome model if they endorsed or exhibited at least three of the symptoms described
above and intermediately frail if they endorsed one or two symptoms (49).
Medical Burdens
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The medical burdens model, conceived by Rockwood and colleagues, defines frailty as
an accumulated burden of diseases, functional disabilities and other health-related deficits and
symptoms. The primary metric used to determine presence of frailty in the medical burdens
model, the frailty index (FI), is calculated as the ratio of present deficits to the number of total
possible deficits considered in the study (e.g. FI=10/30=.33). The medical burdens model is
designed to provide a flexible measure of frailty that may be utilized and compared across
multiple surveys (17, 80). Therefore, the deficits included in the FI calculation are non-specific
provided they satisfy certain inclusion criteria: 1) a deficit must accumulate with age, 2) a deficit
must not become universally prevalent at an early age (e.g. presbyopia), 3) a deficit must be
related to health status in a biologically plausible way, and 4) the deficits considered together
must represent a range of bodily systems, and 5) the deficits making up a FI must be consistent
across time (80). While there is no maximum or minimum number of deficits which may be
included in a FI, prior studies suggest that frailty indices composed of 30 to 40 deficits have
sufficient specificity to predict adverse health outcomes (17, 80). The current study used a FI
consisting of 30 deficits satisfying the inclusion criteria outlined here (Appendix 4.2). Frailty
status was determined using cutoff criteria established in prior studies: participants with a FI
score > 0.25 were considered to be frail while those with a score between 0.15 and .25 were
considered intermediately frail (21, 48).
Functional domains
Strawbridge and colleagues define frailty as functional impairment in at least two of four
domains: physical, nutritive, cognitive, and sensory (24). Consistent with prior
operationalizations of this model, participants were considered to have impairment in physical
functioning if they reported persistent dizziness or lightheadedness, experienced at least one fall
63

within the past two years, or have difficulty lifting or carrying weights over 10 pounds.
Impairment in nutritive functioning was defined as a loss of 10% or more in BMI since the
previous (2008) wave or a current BMI <18.5 kg/m2. Cognitive functioning was assessed using a
35-point composite measure of mental status, reasoning and memory task performance
developed in the HRS (62, 82). Cognitive impairment was defined as a score of 10 or less on the
HRS cognitive performance measure. Sensory impairment was defined as having fair/poor selfrated vision despite use of corrective lenses or fair/poor hearing despite use of a hearing aid.
Participants with impairment in at least two domains were considered frail whereas participants
with impairment in a single domain were considered intermediately frail.
Depressive Symptoms
Depressive symptoms were indexed using the 8-item Center for Epidemiological Studies
– Depression scale (CESD) (59). The CESD asks respondents to report whether they experienced
eight symptoms much of the time during the past week: 1) felt depressed 2) felt activities were
efforts, 3) had restless sleep, 4) felt happy, 5) felt lonely, 6) enjoyed life, 7) felt sad, 8) felt
unmotivated (could not get going). Positive symptoms of feeling happy and enjoying life were
reverse-coded, so that their absence indicated a depressive symptom. The CESD is not a
structured interview meant to emulate clinician diagnosis of major depression; however, prior
studies have shown that when used as a diagnostic substitute (using a cutoff of four or more
symptoms to indicate depression), the CESD has moderate agreement with structured diagnostic
instruments such as the Composite International Diagnostic Interview (CIDI) (59, 60). In the
current study, participants who endorsed four or more symptoms were considered to be
depressed. Depression was assessed using a dichotomous variable (1=depressed, 0=not
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depressed) at each wave of the HRS, allowing the presence of depression for individuals to vary
over time.
Outcome Measures
The current study considered frailty trajectories in relation to two adverse health
outcomes: nursing home admission and serious falls. Nursing home admission was assessed
using a dichotomous variable (1=any nursing home stay, 0=no nursing home stay) indicating
whether a respondent had been a patient overnight in a nursing home, convalescent home, or
other long-term health care facility in the preceding two years. This variable encompassed both
short stays (e.g., for rehabilitation after a hospital discharge) as well as longer stays. Analysis
was repeated considering only those respondents whose nursing home stays were longer than 30
days as experiencing a nursing home stay. We considered ‘serious falls’ as any fall within the
past two years which resulted in injury requiring medical treatment as reported by the
respondent. Respondents who experienced a fall which did not result in injury were considered
not to have experienced a serious fall. A dichotomous variable (1=experienced a serious fall,
0=did not experience a serious fall) was used in analysis.
Time-invariant Covariates
Sociodemographic characteristics and other health related variables were chosen for
inclusion as time-invariant covariates in analysis through a forward selection change-in-estimate
procedure: First, bivariate logistic regression of frailty status and each of the adverse health
outcomes (nursing home stays, falls) at baseline were fit; second, covariates were added
individually to the logistic regression and variables producing the largest change in estimate of
the frailty/outcome relationship were included as potential confounders; third, addition of

65

covariates to the logistic regression continued until individual covariates no longer produced a
substantial change in estimate (> 10%) (99).
Based on the change-in-estimate selection procedure, time-invariant covariates
considered in analysis were sex (male=0; female=1), race (dummy variables for white, black,
and other), years of education (12 or more years=0; fewer than 12 years=1), primary health
insurance provider (dummy variables indicating private, Medicare, and Medicaid insurance),
marital status (dummy variables for currently married/partnered, separated/divorced/never
married, and widowed), smoking status (1=current smoker, 0=not current smoker), and
household poverty-to-income ratio (0=above poverty threshold; below poverty threshold=1).
Age was assessed in 10-year categories (65-75 years, 75-85 years, and greater than 85 years).
ANALYSIS
Growth of frailty and adverse health outcomes over time was modeled using latent
growth curve modeling (LGCM). LGCM is a statistical procedure built on confirmatory factor
analysis (CFA) approaches (83) used to estimate underlying latent (unobserved) growth
parameters that give rise to estimates and interrelations among a set of observed repeated
measures. In a LGCM framework, the growth parameters are used to describe average latent
linear or non-linear trajectories of change over time, as well as individual variability in those
growth trajectories (100). LGCM is an appropriate approach to for modeling longitudinal change
for four reasons: 1) it allows for tests of overall model fit, 2) it allows for regression of intercept
and slope estimates on other explanatory variables and growth parameters while accounting for
imperfect measurement, 3) it can be used to model growth in categorical observed measures, and
4) it allows straightforward incorporation of time-varying explanatory covariates (100). More
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detailed discussions of the theoretical and mathematical bases of LGCM are available elsewhere
(100).
Unconditional and Conditional Latent Growth Models
In the current study, LGC models were built in a hierarchy of increasing complexity.
First, unconditional models of each of the three frailty models and two primary outcomes were
fit to assess overall growth in these constructs over time, unadjusted for influence of covariates.
Two types of growth, linear and quadratic, were modeled for each outcome and compared in
terms of overall model fit and parsimony. Linear growth was specified by constraining the
loadings of the latent growth parameters on the observed outcomes to assume incremental
change per increase in unit time (Figure 4.1). That is, the factor loading for slope was fixed to 0
for Wave 1 frailty status, to 1 for Wave 2 frailty status, to 2 for Wave 3 frailty status, and so on.
Quadratic growth was modeled by the addition of a quadratic latent growth parameter and by
fixing factor loadings of the quadratic term to assume exponential change. Because outcomes
were modeled as dichotomous variables, the growth factors were interpreted as describing the
change in underlying latent propensity of the outcome under a continuous threshold model. That
is, increasing levels of latent propensity toward frailty predict the likelihood of reaching a
threshold distinguishing frail and not frail individuals.
Time-invariant covariates were subsequently added to the unconditional models to assess
influence of these variables on the growth parameters (Figure 4.2). The growth parameters
represent continuous variables, and thus estimates were interpreted as linear regression
coefficients explaining the change in growth parameter (e.g. intercept), associated with each
change in unit of the covariate. Growth parameters and model fit statistics from conditional
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models were compared with those from unconditional models to assess influence and
explanatory significance of the covariates.
Parallel Process Models and Time-varying Depression
Building on conditional growth models, the next set of models addressed the relationship
between trajectories of frailty and change in the propensity to experience adverse health
outcomes. In these models, two growth processes (e.g. growth of frailty and expected change in
the propensity to be admitted to a nursing home stay), were related through the regression
(correlation) of their growth parameters (Figure 4.3). The intercept (initial level) and the slope of
change of each adverse health outcome propensity were regressed on the intercept and slope of
change in frailty for each of the frailty models. The growth parameters for each process were
conditioned upon the time-invariant covariates introduced in preceding models.
Next, to address the secondary aim of the current study, depression status was introduced
into the parallel process models as a time-varying predictor of frailty at each corresponding
wave. Relationships between the dichotomous variables of depression and frailty were estimated
in terms of log odds of being frail comparing depressed and non-depressed respondents. The
influence of frailty growth parameters on growth parameters of adverse health outcomes were reestimated and compared to estimates unadjusted for depression status.
Model estimation and fit criteria
All LGCMs were estimated using maximum likelihood and weighted least squares means
and variance adjusted (WLSMV) estimation as implemented in Mplus software version 7
(Muthén & Muthén, Los Angeles, CA). Model fit was assessed using standard fit criteria:
Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), and root mean square error of
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approximation (RMSEA). Values of CFI >.95, TLI >.95, and RMSEA <.05 were taken to
indicate close model fit to the data (85). All p-values refer to two-tailed tests.

RESULTS
At the 2004 HRS interview (baseline for this analysis), all 10,611 respondents in the
analytic sample were between 55 to 95 years old. Approximately 61% were female, 84% white,
and 70% were married, with a range of other sociodemographic and health related characteristics
described in Table 4.1. The three frailty models produced substantially different estimates of the
number of frail individuals in the sample at baseline, ranging from approximately 8.4%
according to the biological syndrome model to 27.4% according to the medical burdens model.
The characteristics of frail older adults for each definition were similar (Table 4.1): frail
respondents were older and were more likely to be female, had less education, were more likely
to be widowed or divorced/separated, and were more likely to have a household income below
the poverty threshold. Notably, the functional domains model identified a higher proportion of
black respondents as frail compared to the other two definitions (21.4% vs. 14.4% for the
biological syndrome and 16.0% for the medical burdens models). The proportion of frail older
adults in the sample increased over the study period for all frailty definition (Table 4.2). In the
final wave of analysis, the point prevalence of frailty was approximately 44% according to the
medical burdens model, 34% according to the functional domains model, and approximately
21% according to the biological syndrome model.
Unconditional Latent Growth Models
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Parameter estimates from unconditional latent growth models of frailty and risk of
nursing home entry or falls are displayed in Table 4.3. Compared to linear growth models,
quadratic growth models did not provide significantly better model fit for any of the frailty
definitions or adverse health outcomes, and so only results from linear growth models are
hereafter reported (data not shown). As shown in Table 4.3, the mean slope of frailty propensity
was significantly positive for each of the three frailty definitions over time (Functional Domains:
β=.182, p<.001; Medical Burdens: β=.078, p<.00; Biological Syndrome: β=.375, p=.01),
reflecting an increasing expected likelihood of being considered frail over the study period. The
variances of each of the frailty intercept and slope parameters were also statistically significant,
suggesting that there is significant variability in initial level of frailty and in the change of frailty
propensity between individuals over time. As seen in Figures 4.5-4.7, model estimated
probabilities of frailty accurately predicted the observed sample proportions of frailty in the
study population and model fit criteria reflect close model fit for each definition. This indicates
that the specified linear growth model is appropriate for describing change of frailty over time.
The mean and variance of slope for nursing home stay was not significantly different
from zero, suggesting that, unconditioned on predictors, the propensity of needing a nursing
home stay did not increase or decrease over time and was not significantly different among
individuals. The slope of change for experiencing a serious fall was also not significantly
different from zero and moderately negative, suggesting that the mean likelihood of experiencing
a serious fall did not change over time.
Conditional Latent Growth Curve Models
Parameter estimates and covariate regressions from conditional growth models of frailty
are displayed in Tables 4.4 and 4.5. Model fit improved moderately with the addition of
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explanatory covariates according to RMSEA and remained similar according to CFI and TLI.
Slope and intercept growth factors remained significantly greater than zero, suggesting that even
after adjusting for the influence of time-invariant covariates, the mean likelihood of frailty
increased over the study period. Similarly, the significant variances of slope and intercept for
each frailty definition suggest that there was significant heterogeneity in trajectories of frailty
over time not explained by these fixed characteristics. Regression of intercept growth parameters
on covariates indicated that being female, divorced, having less education, being a current
smoker, and having low income were significantly associated with higher baseline levels of
frailty. Each 10 year increase in age above 55 was also associated with higher initial levels of
frailty. While initial level of functional domains frailty was significantly greater among widows
and among black and other race participants (compared to whites), widowhood and race were not
significantly associated with baseline levels of frailty according to the other definitions.
Regressions of slope parameters on time-invariant covariates revealed further differences
in growth of frailty according to the three definitions. Being female, divorced, and of black race
was associated with increasing frailty over time according to the biological syndrome model
only. Whereas lower educational attainment and income were associated with higher initial
levels of medical burdens frailty, these characteristics did not have significant influence on rate
of change in medical burdens frailty over time. Older age and current smoking were associated
with higher rates of growth in all three definitions of frailty. Results from conditional growth
models of adverse health outcomes are presented in Appendix 4.3-4.4.
Parallel Process Models
Further analysis explored the association between frailty growth and the propensity to
experience adverse health outcomes. Table 4.6 details the results from regressions and
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covariances relating the growth parameters of each frailty definition with growth parameters for
nursing home stay for models both unadjusted and adjusted for depression. Not accounting for
the influence of depression, initial level of frailty was correlated with greater baseline likelihood
of requiring a nursing home stay for all frailty definitions. Initial level of frailty was not,
however, directly related to change in nursing home propensity over time. For all frailty
definitions, greater slope of change for frailty was associated with greater slope in nursing home
probability (Functional Domains: β=.594, p<.001; Medical Burdens: β=.771, p<.001; Biological
Syndrome: β=.333, p<.001), suggesting that growth in frailty was significantly associated with
propensity to needing nursing home care. That is, higher rates of frailty change were
significantly associated with more rapid increase in the likelihood of experiencing nursing home
admission.
When depression status was incorporated into parallel process models as a time-varying
covariate, concurrent depression was a significant predictor of frailty at each wave and for each
frailty definition. Participants with depression had on average between 50% and 140% higher
odds of frailty depending on the wave and definition of frailty, as seen in Table 4.6. The
inclusion of depression into parallel process models also significantly changed estimates of
associations between growth parameters. Regression coefficients describing the relationship
between frailty slope and slope in nursing home propensity were diminished and non-significant
after accounting for depression (Functional Domains: βconditional on time-invariant covariates= 0.594,
p<.001 vs. βaccounting for time-varying depression=0.476, p=.857; Medical Burdens: βconditional on time-invariant
covariates=

0.889, p<.001 vs. βaccounting for time-varying depression=0.771, p=.853; Biological Syndrome:

βconditional on time-invariant covariates= 0.333, p<.001 vs. βaccounting for time-varying depression=0.251, p=.832),
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suggesting that depression status explained a significant portion of the variation in nursing home
propensity over time.
Parallel process models with serious falls as the adverse health outcome are displayed in
Table 4.7. Unlike nursing home stay, initial frailty level (intercept) was significantly associated
with both initial propensity for experiencing a serious fall and higher rate of change in this
propensity over time (Functional Domains: β=1.759, p<.001; Medical Burdens: β=1.782, p<.001;
Biological Syndrome: β=1.306, p<.001). As with nursing home stays, addition of depression as a
time-varying covariate reduced the association between frailty slope and slope of propensity for
fall; however, these estimates remained significant depression (Functional Domains: βconditional on
time-invariant covariates=

1.759, p<.001 vs. βaccounting for time-varying depression=1.193, p=.001; Medical

Burdens: βconditional on time-invariant covariates= 1.782, p<.001 vs. βaccounting for time-varying depression=1.366,
p<.001; Biological Syndrome: βconditional on time-invariant covariates= 1.306, p<.001 vs. βaccounting for timevarying depression=0.977,

p=.001)

DISCUSSION
There were two primary aims to the current study. First, we used LGCM to model frailty
change over time and to assess whether both initial level of frailty and change in frailty over time
was associated with experience of adverse health outcomes using three competing definitions of
frailty. We accounted for the influence of time-invariant covariates on frailty trajectories using
conditional LGCM. The second aim was to evaluate the influence of depression as a timevarying covariate on the relationship between frailty and adverse health outcomes. Our results
indicate that, regardless of the operationalization of frailty employed, the predictive relationship
between frailty and risk of nursing home entry and serious falls is substantially reduced (and in
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the case of nursing home admission, essentially null) after accounting for depression status.
Results of these aims provide valuable insights into the dynamic nature of frailty syndrome in
later life and its relationship with depressive symptoms.
Frailty growth and adverse health outcomes
Building on prior frailty research, analysis showed that frailty is a dynamic condition and
that the influence of this condition on adverse health outcomes extends beyond frailty status at a
single time-point. Unconditional LGCM showed that, on average, the expected level of frailty
increased over the study period and that there was significant inter-individual variability in both
the initial level and rate of change of frailty over time. Regardless of the conceptual basis and
operationalization of frailty, the probability of being frail approximately doubled over the study
period. This finding highlights the importance of modeling initial frailty status in conjunction
with change in frailty status over time, as our findings indicate that both have independent
relationships with adverse health outcomes over time. Indeed, parallel process models showed
that greater rates of change in frailty were significantly associated with more rapid increase in
the likelihood of experiencing serious falls as well as nursing home admission. The reliability of
these findings across multiple definitions of frailty indicates that frailty development is an
important consideration which is not reserved for any particular conceptual orientation.
These results supplement what is currently known about frailty and its development over
the life course. While there is an implicit acknowledgement that the signs of frailty may arise
over long periods of time (54), few studies have incorporated frailty change explicitly in
analysis. Many studies have assessed the role of frailty as a static predictor of poor health (21,
49), but the current results extend this research by providing evidence that developmental
trajectories of frailty are themselves important predictors of poor outcomes. The distinction
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between baseline frailty and frailty trajectories is valuable as it may lead to more refined
identification of vulnerable older adults. The more rapid accumulation of frailty symptoms and
indicators over time may signal increased vulnerability to poor health outcomes and higher
health service utilization, even among individuals who would not meet standard criteria for
frailty. Future research in frailty would benefit from focus on trajectories of frailty symptom
accumulation, as slowing the progression of frailty symptoms might provide therapeutic targets
independent of frailty status.
Predictors of frailty levels and trajectories
The time-invariant conditional LGCM of frailty provide further insights into potentially
important differences between competing definitions of this syndrome. For example, more
education and higher income were associated with lower initial probability and lower rate of
change in frailty for the functional domains and biological syndrome definitions, consistent with
literature on social disparities in disability (101, 102). However, these factors did not
significantly influence change in medical burdens frailty over time. This difference might reflect
the medical burden definition’s emphasis on chronic disease states which may be less malleable
to the influence of compensatory resources (e.g. education and wealth) over time. Likewise,
female gender was significantly associated with rate of change of frailty only according to the
biological syndrome definition. A potential explanation for this difference is that the biological
syndrome definition emphasizes sarcopenia and muscle weakness which may be more common
among women (19, 47). Taken together, these findings are in accordance with prior research
demonstrating marked differences in the identification of frail individuals produced by
competing definitions (48). This study builds on this research by showing that competing frailty
definitions may also lead to different conclusions about the factors and characteristics which
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determine the presence of and predict the development of frailty. The choice of frailty definition
can therefore have considerable impact on how frailty is studied and treated, and who is
considered “high risk.”
The longitudinal relationship between frailty and depression
These results provide evidence for the hypothesis that frailty and depression are two
highly interrelated conditions in late-life. When depression status was introduced into models as
a time-varying covariate, the association between frailty and serious falls was substantially
diminished and the association with nursing home entry became non-significant. This indicates
that depression status and frailty status explain much of the same variation in determining which
individuals experience adverse health outcomes over time. There are a number of potential
explanations for these findings. One possibility is that frailty and depression independently lead
to similar poor health outcomes. While frailty and depression are both associated with poor
health (49, 94), it is unlikely, given their pervasive comorbidity and established diagnostic
overlap (40, 75), that they are wholly independent of one another. A more likely explanation is
that frailty and depression are comparable, but distinct, expressions of a more general underlying
process of physiological and psychosocial decline. For example, age-associated cardiovascular
changes play a role in development of both frailty and depression (67, 86-88), and may help to
explain comorbidity and common consequences of the two conditions. Consistent with this
hypothesis, Hajjar and colleagues have identified an age-related phenotype characterized by
depressive symptoms and features of frailty such as slow gait speed and poor executive
functioning (67); hypertension, diabetes and other cardiovascular disorders were independently
associated with this phenotype (67).
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Other explanations, for instance that depression is a cause of or prodromal state of frailty
(38), cannot be discounted based on the current analysis. Nonetheless, findings regarding the
joint influence of frailty and depression on poor health outcomes signal the need for more
comprehensive investigations of geriatric syndromes like frailty. Incorporating, rather than
excluding, depression as a primary measure in frailty research will help to merge two separate
lines of investigation from frailty and late-life depression. Joint consideration of frailty and
depression may also help to identify older adults at higher risk and to tailor treatment to address
both physiological and psychosocial vulnerabilities (45).
The primary strength of this study lies in the use of LGCM in a population-based sample.
To our knowledge, this is among the first applications of LGCM to understanding change in
frailty over time. LGCM allows us to address the question of whether frailty trajectories are
associated with poor health outcomes independently of baseline frailty status and allows
straightforward inclusion of time-varying covariates in analysis. Furthermore, the robustness of
the findings is strengthened by replication across multiple definitions of frailty and multiple
adverse health outcomes. Comprehensive analysis is possible because of the extensive collection
of longitudinal health information and large sample size available in the HRS.
This study also has several limitations. First, while the parameters describing growth of
frailty propensity over time were represented as latent factors, frailty itself was considered as a
dichotomous, observed variable. To the extent that definitional criteria imperfectly measure the
underlying frailty construct, our model results may misrepresent the relationship between frailty
and other variables. However, frailty status for each of the three definitions was dichotomized
according to standard criteria used extensively in previous research (21, 24, 48-50). Also,
categorization of frailty as a discrete condition renders it clinically sensible as a basis for
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treatment and intervention. Second, the measure of depression used in this study, the CESD, is
not designed as a substitute for clinician diagnosis of major depression, and may not accurately
distinguish depressed from non-depressed individuals. Nonetheless, the CESD is among the most
widely used measures for depressive symptoms in the general community and thus its
relationship with common measures of frailty is of research significance. Furthermore, the CESD
has moderate diagnostic agreement with structured instruments for the assessment of major
depression such as the CIDI (36, 37) and elevated depressive symptoms indicated by this scale
have been associated with a host of adverse health outcomes that are also predicted by more
clinically-validated metrics of depression (103, 104). Finally, the analytical sample was restricted
to participants who were interviewed in each wave of the HRS from 2004 to 2012. By excluding
participants lost to follow-up, it is possible that the study sample was healthier and less frail than
individuals in the general population. Because both frailty status and adverse health outcomes are
associated with increased likelihood of mortality, conditioning analysis on study retention may
introduce bias by diminishing the observed relationship between frailty, depression, and adverse
health outcomes. Despite this, the current study found a robust association between frailty and
adverse health outcomes across multiple definitions of frailty. A more comprehensive
understanding of this relationship could be gained by future studies accounting for competing
risks such as mortality (105).
In summary, these results provide another step in understanding frailty’s role as a
measure of vulnerability in older adults. LGCM showed that more rapid development of frailty,
as measured by three common definitions, was associated with propensity for falls and nursing
home stays. Furthermore, models suggest that depression plays a substantial role in explaining
the risk of poor health conferred by frailty, regardless of how it is operationalized. Results
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indicate the need for interdisciplinary research, and inter-professional collaboration, to promote
health and well-being in later life.
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Table 4.1. Baseline (Wave 2004) sample characteristics by frailty definition

Total
N=10,611
Characteristic

% or
Mean (sd)

Characteristics among Frail Older Adults
Functional
Medical
Biological
Domains
Burdens
Syndrome
Frail
Frail
Frail
N = 1,768
N = 2,903
N = 864
% or
% or
% or
Mean (sd)
Mean (sd)
Mean (sd)

Age (yrs)
67.3 (7.9)
69.5 (8.7)
Female
60.7
66.7
Race
White
84.0
75.3
Black
13.5
21.4
Other
2.4
3.2
Education (>12 yrs)
43.0
27.2
Household Poverty
7.7
16.6
Marital Status
Married/partnered
69.2
57.3
Separated/divorced
10.8
13.8
Widowed
17.3
25.2
Health Insurance
Medicare
60.8
75.4
Medicaid
6.4
17.4
Private
19.6
19.0
Current smoker
12.4
15.3
1
Biological syndrome: frail = 3 or more symptoms
2
Medical burdens: frail = index score >.25
3
Functional domains: frail = 2 or more symptoms
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68.1 (8.2)
72.8

69.5 (9.2)
70.1

81.1
16.0
3.0
32.6
12.8

83.7
14.1
2.2
30.6
16.2

61.9
13.5
21.6

59.6
14.4
22.6

69.3
13.3
20.2
14.4

73.1
17.2
19.4
15.5

Table 4.2. Proportion frail by frailty definition and wave

Characteristic
Wave 1 (2004)
Frail
Intermediate
Wave 2 (2006)
Frail
Intermediate
Wave 3 (2008)
Frail
Intermediate
Wave 4 (2010)
Frail
Intermediate
Wave 5 (2012)
Frail
Intermediate

Functional
Domains
N (%)

Frailty Definition
Medical
Burdens
N (%)

Biological
Syndrome
N (%)

1,768 (17.1)
3,510 (33.1)

2,903 (27.4)
2,605 (24.5)

864 (8.4)
3,397 (32.0)

1,978 (19.0)
3,612 (34.0)

3,337 (31.5)
2,839 (26.8)

1,331 (12.5)
4,061 (38.3)

2,231 (21.4)
3,790 (35.7)

3,857 (36.4)
2824 (26.6)

1,649 (15.8)
4,171 (39.3)

2,906 (27.9)
3,705 (34.9)

4,159 (39.2)
2,756 (26.0)

2,043 (19.3)
4,795 (45.2)

3,482 (33.8)
3,629 (34.2)

4,697 (44.3)
2,566 (24.2)

2,130 (20.7)
4,669 (44.0)

1

Biological syndrome: frail = 3 or more symptoms; intermediate = 1 or 2
symptoms
2
Frailty index: frail = index score >.25; intermediate = index score >.15
3
Functional domains: frail = 2 or more symptoms; intermediate = 1
symptom
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Table 4.3. Unconditional latent growth models of frailty and adverse health outcomes
Functional
Domains
pEstimate Value

Medical
Burdens
Estimate

pValue

Biological
Syndrome
pEstimate Value

Nursing Home
Stay
pEstimate Value

Serious
Falls
Estimate

pValue

Model Fit Statistics
CFI
TLI
RMSEA

0.995
0.992
0.042

-------

0.999
0.999
0.036

-------

0.955
0.925
0.069

-------

0.995
0.991
0.019

-------

0.982
0.971
0.023

-------

Means
Slope
Intercept

0.182
0

<.001
---

0.078
0

<.001
---

0.375
0

0.010
---

-0.032
0

0.763
---

-0.362
0

0.169
---

Variances
Slope
Intercept

0.019
0.666

<.001
<.001

0.031
0.887

<.001
<.001

0.036
0.880

0.049
<.001

0.809
0.098

<.001
0.003

0.733
0.141

<.001
0.063

-0.044

0.169

Covariances
Slope with Intercept
-0.096
<.001
0.015
0.361
0.166
0.041
-0.016
0.578
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of approximation
All p-values are two-tailed
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Table 4.4. Growth parameter estimates, model fit criteria from conditional latent growth
models with time-invariant predictors

Model Fit Criteria
CFI
TLI
RMSEA

Functional
Domains
pEstimate Value
0.990
--0.983
--0.020
---

Medical
Burdens

Biological
Syndrome
ppEstimate Value Estimate Value
0.999
--0.953
--0.998
--0.923
--0.015
--0.028
---

Growth Parameters
Random effect mean
Slope
0.195
<.001
0.117
<.001
0.060
<.001
Intercept
0.162
<.001
0.119
<.001
0.271
<.001
Variances
Slope
0.076
<.001
0.048
<.001
0.774
0.049
Intercept
0.735
<.001
0.904
<.001
1.154
<.001
Covariances
Slope with Intercept
0.039
<.001
0.045
0.361
0.268
0.012
CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error
of approximation; All p-values are two-tailed
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Table 4.5. Relationship between time-invariant predictors and initial level of and change
in level of frailty

Covariates
Intercept on covariate
Gender
Race (ref: white)
Black
Other
Divorced (ref: married)
Widow (ref: married)
Age (ref: 55-65 yrs)
65 to 75 yrs
75 to 85 yrs
85+ yrs
Education (ref: HS or less)
Current smoker
Poverty
Slope on covariate
Gender
Race (ref: white)
Black
Other
Divorced (ref: married)
Widow (ref: married)
Age (ref: 55-65 yrs)
65 to 75 yrs
75 to 85 yrs
85+ yrs
Education (ref: HS or less)
Current smoker
Poverty

Functional
Domains
pβ
Value

Medical
Burdens
pβ
Value

Biological
Syndrome
pβ
Value

0.079

0.003

0.401

<.001

0.201

<.001

0.278
0.336
0.130
0.091

<.001
<.001
0.001
0.012

0.032
0.051
0.203
0.043

0.321
0.430
<.001
0.214

0.026
0.050
0.178
-0.043

0.558
0.546
<.001
0.353

0.240
0.472
0.643
-0.381
0.198
0.531

<.001
<.001
<.001
<.001
<.001
<.001

0.188
0.317
0.505
-0.296
0.151
0.433

<.001
<.001
<.001
<.001
<.001
<.001

-0.062
0.301
0.563
-0.230
0.157
0.449

0.094
<.001
<.001
<.001
<.001
<.001

-0.007

0.539

0.022

0.209

0.276

0.001

0.040
0.042
0.008
0.028

0.100
0.231
0.667
0.110

-0.003
-0.041
0.021
0.034

0.775
0.040
0.155
0.007

0.107
0.072
0.179
0.163

0.024
0.361
0.010
<.001

0.087
0.290
0.448
-0.100
0.036
0.132

0.002
<.001
<.001
0.004
<.001
0.007

0.095
0.201
0.191
-0.018
0.032
0.026

<.001
<.001
<.001
0.197
0.015
0.237

0.626
1.117
1.151
-0.368
0.277
0.265

<.001
<.001
<.001
<.001
0.001
0.012

CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of
approximation; All p-values are two-tailed
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Table 4.6. Parallel process models adjusting for time invariant covariates and time-varying
depression (Outcome: nursing home admission)
Functional
Domains
pEstimate Value
Model Fit Statistics
CFI
TLI
RMSEA

Parameter
Growth parameter regressions
unadjusted for depression
Frailty Intercept on NH Slope
Frailty Slope on NH Slope
Frailty Intercept with NH
Intercept
Growth parameter regressions
adjusted for depression
Frailty Intercept on NH Slope
Frailty Slope on NH Slope
Frailty Intercept with NH
Intercept

Parameter
Frailty regression on time-varying
depression
Time 1
Time 2
Time 3
Time 4
Time 5

Medical
Burdens
Estimate

pValue

Biological
Syndrome
pEstimate
Value

0.993
0.989
0.012

-------

0.998
0.997
0.012

-------

0.970
0.952
0.018

-------

β

pValue

β

pValue

β

pValue

0.036
0.594

0.227
<.001

-0.011
0.889

0.620
<.001

0.002
0.333

0.933
<.001

0.200

<.001

0.331

<.001

0.311

<.001

0.009
0.476

0.986
0.857

0.002
0.771

0.998
0.853

-0.011
0.251

0.982
0.832

0.170

<.001

0.350

<.001

0.299

0.002

log odds

pValue

log odds

pValue

log odds

pValue

0.510

<.001

0.581

<.001

0.522

<.001

0.405
0.568
0.566
0.791

<.001
<.001
<.001
<.001

0.580
0.635
0.655
0.894

<.001
<.001
<.001
<.001

0.545
0.721
0.611
0.723

<.001
<.001
<.001
<.001

CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of
approximation
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Table 4.7. Parallel process models adjusting for time invariant covariates and time-varying
depression (Outcome: serious fall)
Functional
Domains
pEstimate Value
Model Fit Statistics
CFI
TLI
RMSEA

Medical
Burdens
Estimate

pValue

Biological
Syndrome
pEstimate Value

0.988
0.981
0.015

-------

0.996
0.994
0.016

-------

0.962
0.942
0.020

-------

β

pValue

β

pValue

β

pValue

Growth parameter regressions
unadjusted for depression
Frailty Intercept on Fall Slope
Frailty Slope on Fall Slope
Frailty Intercept with Fall Intercept

0.403
1.759
0.161

0.002
<.001
<.001

0.281
1.782
0.221

0.001
<.001
<.001

0.192
1.306
0.164

0.007
<.001
<.001

Growth parameter regressions adjusted
for depression
Frailty Intercept on Fall Slope
Frailty Slope on Fall Slope
Frailty Intercept with Fall Intercept

0.211
1.193
0.149

0.021
0.001
<.001

0.192
1.366
0.200

0.009
<.001
<.001

0.093
0.977
0.120

0.085
0.001
0.001

log odds

pValue

log odds

pValue

log odds

pValue

0.510
0.410
0.581
0.585
0.827

<.001
<.001
<.001
<.001
<.001

0.582
0.582
0.640
0.661
0.905

<.001
<.001
<.001
<.001
<.001

0.522
0.563
0.746
0.638
1.800

<.001
<.001
<.001
<.001
<.001

Parameter

Parameter
Frailty regression on time-varying
depression
Time 1
Time 2
Time 3
Time 4
Time 5

CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA: Root-mean-square error of
approximation
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Figure 4.1. Heuristic example of unconditional latent growth curve model for functional domains
frailty
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Figure 4.2. Heuristic example of conditional latent growth curve model for functional domains
frailty
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Figure 4.3. Parallel process model of functional domains frailty and nursing home stays
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Figure 4.4. Parallel process model adjusted for time-varying depression
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Figure 4.5. Sample proportions and model estimated probabilities for functional domains frailty
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Figure 4.6. Sample proportions and model estimated probabilities for medical burdens frailty
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Figure 4.7. Sample proportions and model estimated probabilities for biological syndrome frailty
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Afterword

Findings from this project have important implications for promoting health and wellbeing among older adults. By clarifying the associations between frailty and depression, this
project informs design of preventive approaches to addressing physiological and psychosocial
vulnerability. This project also highlights important connections between geriatric and
psychiatric research. Bridging these lines of investigation will provide a richer understanding of
the causes and correlates of adverse health events in late life.
Consistent across the three studies that constitute this project, frailty and depression were
found to be highly interrelated syndromes. These findings suggest that frailty and depression
should not be viewed as distinct syndromes but as overlapping and fundamentally linked
conditions. A common approach to research related to frailty definition is to exclude individuals
with depression from analysis; however, studies that aim to examine frailty independently from
depression may imply an artificial distinction between these two syndromes and may draw
incorrect inferences regarding the consequences and causes of frailty (Chapter 4). A more
promising approach to research is to investigate frailty and depression as joint expressions of
underlying decline. This approach is reflected in Hajjar et al. (2009), which identified an agerelated syndrome characterized by symptoms of frailty and depression that was independently
related to cardiovascular disorders (67). The second-order factors detailed in Chapter 3 of this
project provide similar implications of an underlying process influencing both frailty and
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depression. Therefore this project supplements current literature by organizing key findings
within an explanatory structural model that serves as a target for future investigation. The
robustness of findings using three conceptually distinct definitions of frailty offers rationale for
refocusing the study of frailty and depression on their putative substrates. Study of the
mechanisms and biologically plausible explanations of comorbidity of frailty and depression
may lead to more effective ways to prevent and or treat these conditions jointly and
independently.
This project likewise serves to unite research in frailty with guiding principles from
geriatric psychiatry. In geriatric psychiatry, generative hypotheses regarding the causes of and
alternate presentations of depression among older adults have led to important advances in
understanding of depression. For instance, the ‘vascular depression hypothesis,’ which proposes
that vascular mechanisms underlie many cases of late-onset depression, has guided search for
causal explanations of depression among older adults (88, 106). Likewise, evidence suggests that
depression among older adults is often characterized by a relative lack of mood-related
symptoms and a preponderance of vegetative or somatic symptoms such as sleep disturbance and
fatigue (41, 96). This phenomenon, termed ‘depression without sadness,’ has informed the
development of more accurate survey measurements of depression among older adults and has
provided avenues for future investigations of age differences in depression (41, 96). Though
these findings from geriatric psychiatry may signal potential connections between frailty and
depression, research on frailty has progressed, for the most part, independent of input from this
related field. By presenting a basis for comparison between frailty and depression research, the
current project may help to encourage refinement of the frailty concept and therefore more
accurate identification of frail older adults. More accurate identification of frailty would
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ostensibly improve recommendations for care and allocation of limited health resources for older
adults.
The current project has implications for clinicians seeking to provide effective therapy for
frail older adults. Comorbidity of frailty and depression may signal an elevated risk of adverse
health outcomes (45). Frail older adults with depression may benefit from more holistic
approaches to care which address not only physiological vulnerability but also the psychosocial
vulnerabilities represented by depression (45). In support of this idea, the current project found
that both depression and frailty were independently associated with risk of adverse health
outcomes and that both conditions explained variations in who did and did not experience
adverse health outcomes over time. Furthermore, frailty may limit effectiveness of or adherence
to depression treatment, suggesting again that frailty and depression must not be considered
independently of one another in clinical settings (43, 44). To our knowledge, no studies have
investigated treatment approaches specifically aimed at addressing frailty and depression
concurrently. A second implication of the current project is that greater rates of change in frailty
were significantly associated with more rapid increase in the likelihood of experiencing adverse
health outcomes. Thus, frailty trajectories are themselves important predictors of poor health
apart from frailty status. More rapid accumulation of frailty symptoms over time may signal
greater risk of adverse health outcomes. This suggests that delaying or preventing frailty
symptoms may help to prevent adverse health outcomes, even among those who would not be
considered frail by standard cut-off criteria. Tracking longitudinal changes in symptoms of
frailty may then provide more nuanced measures of vulnerability.
Much is still unknown about how to best identify and to care for frail older adults. Future
research should continue to seek the development of a unified frailty definition and to evaluate
96

approaches to caring for frail older adults. The current project provides a foundation for future
research by elucidating frailty’s relationship with depression and describing the joint role of
these syndromes in determining poor health among older adults. The potential public health
benefit of frailty will only be realized when conceptual issues are resolved.
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Appendix

Appendix 3.1. Deficits used to define the frailty index (Chapter 3)
Variable name
Operationalization in HRS
Problems getting dressed
Some difficulty dressing self
Problems with bathing
Some difficulty bathing, shower
Toileting problems
Some difficulty using toilet
Problems cooking
Some difficulty preparing hot meals
Problems going out alone Difficullty shopping for groceries
Change in everyday
Change in activities of daily living
activities
Impaired mobility
Some difficulty walking across room, walking several blocks,
climbing stairs
Falls
Any reported falls past 2 years
Poor muscle tone limbs
Difficulty in large muscle activities (e.g. stooping, chair stand,
kneeling, pushing large object)
Poor limb coordination
Difficulty in fine motor skills such as picking up a dime, eating
and dressing
Bradykinesia of limbs
Slow walking speed
Musculoskeletal problems Arthritis, hernia, rheumatism, paralysis, etc.
Hypertension
Reported high blood pressure
Myocardial infarction
Ever had heart attack
Congestive heart failure
Ever had heart failure
Arrhythmia
Ever had abnormal heart rhythm
Other cardiac problems
Ever had angina
History of stroke
Ever had a stroke
History of diabetes
Ever had diabetes
mellitus
Long-term memory
Problem with dementia
impairment
Memory changes
Memory worse than two years ago
History of Parkinson's
Ever have Parkinson's disease
disease
Headache
Persistent headache
Trouble sleeping
Trouble falling asleep or waking up during night
Tiredness all the time
Persistent or troublesome fatigue or exhaustion
Syncope or blackouts
Dizziness, blackouts, meningitis, other neurological problems
Lung problems
Ever have lung disease
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Respiratory problems
Other psychiatric
condition
Feeling sad, blue,
depressed
Gastrointestinal problems
Skin condition
Thyroid trouble
Incontinence
Malignant disease

Persistent couch/wheeze/flem or asthma, emphysema, chronic
bronchitis
Psychiatric conditions not including depression and GAD
Felt depressed in past year
E.g ulcers, colitis, gastritis, diverticulosis
E.g. dermatitis, eczema, rashes
Any thyroid problem
Any reported incontinence past 12 months
Ever had cancer
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Appendix 3.2. Model fit indices from uni-dimensional factor analyses
Biological
Functional
syndrome
Frailty index
domains
CESD
CFI
0.991
0.953
0.97
0.953
TLI
0.984
0.95
0.91
0.962
RMSEA
0.013
0.029
0.036
0.082
Exploratory analysis found that the model fit of the medical burdens frailty
model was significantly improved when modeled as a second order factor with
three sub-dimensions generally corresponding to activities of daily living,
cardiovascular and neurological symptoms (Appendix 3.1); however, because
frailty is commonly used as a uni-dimensional factor in practice, the frailty
index was modeled as such in subsequent analyses.
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Appendix 4.1. Criteria used to define physical measures symptoms of biological syndrome
model frailty
Grip strength, stratified by gender and body mass index (BMI)
Men
Cutoff for grip strength (kg) criterion
BMI < 24
< 29
BMI 24.1-26
< 30
BMI 26.1-28
< 30
BMI > 28
< 32
Women
BMI < 23
BMI 23.1-26
BMI 26.1-29
BMI > 29

< 29
< 30
< 30
< 32

Walking speed, stratified by gender and height
Cutoff time for 15 feet walking course (scaled
Men
to 2.5 meter for HRS)
Height < 173 cm
> 7 seconds
Height > 173 cm
> 6 seconds
Women
Height < 159 cm
> 7 seconds
Height > 159 cm
> 6 seconds
All cutoff criteria are derived from Fried et al. (2001)
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Appendix 4.2. Deficits used to define the frailty index, medical burdens model (Chapter 4)
Variable name
Problems getting dressed
Problems with bathing
Toileting problems
Problems cooking
Problems going out alone
Change in everyday
activities
Impaired mobility
Falls
Poor muscle tone limbs
Poor limb coordination
Hypertension
Myocardial infarction
Congestive heart failure
Other cardiac problems
History of stroke
History of diabetes
mellitus
Long-term memory
impairment
Memory changes
Headache
Trouble sleeping
Tiredness all the time
Lung problems
Respiratory problems
Other psychiatric
condition
Feeling sad, blue,
depressed
Incontinence
Malignant disease
Arthritis
Trouble with pain
Back pain or back
problems

Operationalization in HRS
Some difficulty dressing self
Some difficulty bathing, shower
Some difficulty using toilet
Some difficulty preparing hot meals
Difficullty shopping for groceries
Change in activities of daily living
Some difficulty walking across room, walking several blocks, climbing
stairs
Any reported falls past 2 years
Difficulty in large muscle activities (e.g. stooping, chair stand, kneeling,
pushing large object)
Difficulty in fine motor skills such as picking up a dime, eating and
dressing
Reported high blood pressure
Ever had heart attack
Ever had heart failure
Ever had angina
Ever had a stroke
Ever had diabetes
Problem with dementia
Memory worse than two years ago
Persistent headache
Trouble falling asleep or waking up during night
Persistent or troublesome fatigue or exhaustion
Ever have lung disease
Persistent couch/wheeze/flem or asthma, emphysema, chronic bronchitis
Psychiatric conditions not including depression and GAD
Felt depressed in past year
Any reported incontinence past 12 months
Ever had cancer
Reported arthritis this wave
Often troubled with pain
Back pain or problems

117

Appendix 4.3. Growth parameter estimates, model fit criteria from
conditional latent growth models with time-invariant predictors
Nursing Home
Serious
Stay
Fall
ppModel Fit Criteria
Estimate Value Estimate Value
CFI
0.997
--0.978
--TLI
0.995
--0.963
--RMSEA
0.005
--0.013
--Growth Parameters
Random effect mean
Slope
Intercept
Variances
Slope
Intercept
Covariance
Slope with Intercept

-0.125
0.132

0.545
<.001

-3.233
1.413

0.003
<.001

0.109
0.646

0.029
<.001

1.459
1.215

0.039
<.001

-0.044

0.080

-0.087

0.261

CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; RMSEA:
Root-mean-square error of approximation
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Appendix 4.4. Growth parameter estimates, model fit criteria from
conditional latent growth models with time-invariant predictors
Nursing Home
Serious
Stay
Fall
ppCovariate Effects
β
Value
β
Value
Intercept on covariate
Gender
0.243
0.001 0.284 <.001
Race (ref: white)
Black
-0.037 0.677 0.126 0.083
Other
-0.558 0.042 0.194 0.27
Divorced (ref: married)
0.253
0.006 0.045 0.601
Widow (ref: married)
0.178
0.013 0.095 0.106
Age (ref: 55-65 yrs)
65 to 75 yrs
0.365
<.001 1.909 <.001
75 to 85 yrs
0.563
<.001 2.013 <.001
85+ yrs
0.762
<.001 2.377 <.001
Education (ref: HS or less)
-0.016 0.791 0.034 0.481
Current smoker
0.056
0.579 0.041 0.612
Poverty
-0.034 0.755 0.153 0.065
Slope on covariate
Gender
Race (ref: white)
Black

-0.029

0.240

0.001

0.982

Other
Divorced (ref: married)
Widow (ref: married)
Age (ref: 55-65 yrs)
65 to 75 yrs
75 to 85 yrs
85+ yrs

0.065
0.011
0.026

0.479
0.763
0.425

0.136
0.323
0.464

0.025
0.006
0.006

Education (ref: HS or less)

-0.025

0.297

Current smoker
Poverty

0.018
0.129

0.600
0.010
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0.416 0.002
0.399
0.439
0.151
0.118
0.545
0.908
1.179
0.041
0.218
0.109

0.002
0.030
0.087
0.105
0.042
0.014
0.013
0.405
0.015
0.269
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